DAMGO和Galantamine对铅暴露大鼠海马DG区突触可塑性的影响和修复作用
|
摘要
慢性铅暴露引发多重学习记忆和认知能力的损害。海马的突触可塑性是学习记忆的重要细胞模型，得到了广泛的重视和研究，包括长时程增强(long-termpotentiation, LTP)和长时程压抑(long-term depression, LTD)两种重要形式。去增强(Depotentiation, DP)是突触可塑性的另外一种形式。以往的研究结果表明，慢性铅暴露可以损伤海马CA1区和齿状回(dentate gyrus, DG)的LTP/LTD诱导。本文用场电位记录方法研究了μ型阿片受体激动剂DAMGO对慢性铅暴露大鼠突触可塑性损伤的影响和Galantamine对慢性铅暴露大鼠突触可塑性损伤的修复和保护作用。研究方法和结果如下：
新生的Wistar大鼠从出生起到断乳通过饮用0.2%醋酸铅溶液染铅。在27-30日龄大鼠海马离体脑片齿状回记录兴奋性突触后电位。结果表明：DAMGO在铅暴露组和control组都诱导得到LTP幅度增加，并且铅暴露组比control组升高更明显。NMDA受体阻断剂AP5不能完全阻断DAMGO诱导的LTP。铅暴露损伤了高频刺激诱导的LTP，DAMGO对这种损伤没有明显的修复，对control组的HFS-LTP也没有明显的影响。结果说明，DAMGO可以在慢性铅暴露组诱导比control组更高的LTP，其机制部分来源于NMDA受体途径的参与；DAMGO对HFS-LTP组别没有明显作用，可能与铅神经毒理作用在两种LTP诱导过程中位点差异有关。
新生的Wistar大鼠自出生到成年通过饮用0.2%醋酸铅溶液染铅。在成年大鼠(60-90日龄)的海马齿状回记录兴奋性突触后电位和群峰电位。进行实验前两周起通过腹腔注射为Galantamine组别动物给药(1 mg/100 g体重每天)。结果显示，慢性铅暴露损伤了大鼠海马DG区LTP/DP的诱导，而Galantamine可以显著的升高铅暴露大鼠LTP/DP的幅度，但是在非铅暴露组只有不明显的升高。这个结果提示Galantamine可以逆转铅导致的大鼠突触可塑性损伤，并且可能是有效的铅所致认知障碍治疗药物。
通过以上的实验，我们研究了DAMGO和Galantamine对慢性铅暴露造成的突触可塑性损伤的影响，了解了可能的作用机制。为进一步了解了铅的神经毒理机制，寻求新的治疗途径提供理论支持。
Chronic lead exposure causes a variety of impairments in learning and memoryand cognitive function. And synaptic plasticity in hippocampus is an extensivelystudied cellular model of learning and memory, which includes long-term potentiation(LTP) and long-term depression (LTD) in two forms. Depotentiation (DP) is anotherform of synaptic plasticity. Previous studies show that chronic lead exposure candamage the induction of LTP/LTD in hippocampal CA1 and dentate gyrus (DG) areas.The studies of thesis were carried out of investigate the effects on chronic lead-causedsynaptic plasticity impairment by DAMGO, a selectiveμ-opioid receptor agonists，and we investigated the repair and protection on lead-caused synaptic plasticityimpairment by Galantamine, using field potential recording on chronic lead exposurerats. The methods and results are as follows：
Neonatal Wistar rats were exposed to lead from parturition to weaning via milkof dams whose drinking water contained 0.2% lead acetate. Field excitatorypostsynaptic potentials (fEPSPs) in DG area of hippocampus were recorded onpostnatal days 27-30. DAMGO application was followed by an increase in EPSPslopes in both control and lead-exposed rats, while the amplitude of DAMGO-LTP inthe lead-exposed rats was significantly greater than that in controls. DAMGO-LTPcan not be blocked by NMDA receptor antagonist AP5 completely. Chronic leadexposure causes impairment in the amplitude of HFS-LTP, and the impairment wasnot significantly affected by DAMGO treatment, the DAMGO application also didnot influence the amplitude of HFS-LTP in control group. These results indicate thatthe amplitude of DAMGO-LTP in lead-exposured group was greater than controlgroup, and it was depends on the activity of NMDA receptor partly. No significanteffect of DAMGO on HFS-LTP groups is the result of different sites of leadneurotoxicity.
Neonatal Wistar rats were exposed to lead from parturition through adulthood bythe drinking of 0.2% lead acetate. Galantamine was applied by intraperitonealinjection every day (1 mg/day/100 g body weight) twoweeks before theelectrophysiological recording. The results showed that chronic lead exposureimpaired LTP/DP induction in DG area of the hippocampus, and Galantamine causeda significant increase on the amplitudes of LTP/DP of lead-exposed rats, but only a small increase in non-exposed group. These results suggest that Galantamine couldreverse the lead-induced impairments of synaptic plasticity in rats and might be aneffective medicine to cure the cognitive deficits induced by lead.
By these experiments, we studied the effects on the chronic lead-exposuredimpairments of synaptic plasticity by DAMGO and Galantamine, and possiblemechanisms. All of these findings provided us a more comprehensive understandingabout the toxicity of lead.
新生的Wistar大鼠从出生起到断乳通过饮用0.2%醋酸铅溶液染铅。在27-30日龄大鼠海马离体脑片齿状回记录兴奋性突触后电位。结果表明：DAMGO在铅暴露组和control组都诱导得到LTP幅度增加，并且铅暴露组比control组升高更明显。NMDA受体阻断剂AP5不能完全阻断DAMGO诱导的LTP。铅暴露损伤了高频刺激诱导的LTP，DAMGO对这种损伤没有明显的修复，对control组的HFS-LTP也没有明显的影响。结果说明，DAMGO可以在慢性铅暴露组诱导比control组更高的LTP，其机制部分来源于NMDA受体途径的参与；DAMGO对HFS-LTP组别没有明显作用，可能与铅神经毒理作用在两种LTP诱导过程中位点差异有关。
新生的Wistar大鼠自出生到成年通过饮用0.2%醋酸铅溶液染铅。在成年大鼠(60-90日龄)的海马齿状回记录兴奋性突触后电位和群峰电位。进行实验前两周起通过腹腔注射为Galantamine组别动物给药(1 mg/100 g体重每天)。结果显示，慢性铅暴露损伤了大鼠海马DG区LTP/DP的诱导，而Galantamine可以显著的升高铅暴露大鼠LTP/DP的幅度，但是在非铅暴露组只有不明显的升高。这个结果提示Galantamine可以逆转铅导致的大鼠突触可塑性损伤，并且可能是有效的铅所致认知障碍治疗药物。
通过以上的实验，我们研究了DAMGO和Galantamine对慢性铅暴露造成的突触可塑性损伤的影响，了解了可能的作用机制。为进一步了解了铅的神经毒理机制，寻求新的治疗途径提供理论支持。
Chronic lead exposure causes a variety of impairments in learning and memoryand cognitive function. And synaptic plasticity in hippocampus is an extensivelystudied cellular model of learning and memory, which includes long-term potentiation(LTP) and long-term depression (LTD) in two forms. Depotentiation (DP) is anotherform of synaptic plasticity. Previous studies show that chronic lead exposure candamage the induction of LTP/LTD in hippocampal CA1 and dentate gyrus (DG) areas.The studies of thesis were carried out of investigate the effects on chronic lead-causedsynaptic plasticity impairment by DAMGO, a selectiveμ-opioid receptor agonists，and we investigated the repair and protection on lead-caused synaptic plasticityimpairment by Galantamine, using field potential recording on chronic lead exposurerats. The methods and results are as follows：
Neonatal Wistar rats were exposed to lead from parturition to weaning via milkof dams whose drinking water contained 0.2% lead acetate. Field excitatorypostsynaptic potentials (fEPSPs) in DG area of hippocampus were recorded onpostnatal days 27-30. DAMGO application was followed by an increase in EPSPslopes in both control and lead-exposed rats, while the amplitude of DAMGO-LTP inthe lead-exposed rats was significantly greater than that in controls. DAMGO-LTPcan not be blocked by NMDA receptor antagonist AP5 completely. Chronic leadexposure causes impairment in the amplitude of HFS-LTP, and the impairment wasnot significantly affected by DAMGO treatment, the DAMGO application also didnot influence the amplitude of HFS-LTP in control group. These results indicate thatthe amplitude of DAMGO-LTP in lead-exposured group was greater than controlgroup, and it was depends on the activity of NMDA receptor partly. No significanteffect of DAMGO on HFS-LTP groups is the result of different sites of leadneurotoxicity.
Neonatal Wistar rats were exposed to lead from parturition through adulthood bythe drinking of 0.2% lead acetate. Galantamine was applied by intraperitonealinjection every day (1 mg/day/100 g body weight) twoweeks before theelectrophysiological recording. The results showed that chronic lead exposureimpaired LTP/DP induction in DG area of the hippocampus, and Galantamine causeda significant increase on the amplitudes of LTP/DP of lead-exposed rats, but only a small increase in non-exposed group. These results suggest that Galantamine couldreverse the lead-induced impairments of synaptic plasticity in rats and might be aneffective medicine to cure the cognitive deficits induced by lead.
By these experiments, we studied the effects on the chronic lead-exposuredimpairments of synaptic plasticity by DAMGO and Galantamine, and possiblemechanisms. All of these findings provided us a more comprehensive understandingabout the toxicity of lead.
引文
安兰敏,牛玉杰,安宝恒2004.铅对大鼠脑细胞一氧化氮合成酶表达的影响.环境与健康杂志[J], 21: 296-297.
曹续政,张黎明,沈月娥2006. NMDA受体介导了加兰他敏对阿尔茨海默病大鼠认知功能的改善.中风与神经疾病杂志[J], 23: 678-680.
曽燕,梁勋厂,施静, et al. 2004.急慢性吗啡应用对外侧穿通纤维-海马CA3直接通路LTP的不同影响.中国药学杂志[J], 39: 822-825.
常艳,薛毅珑2004.阿尔茨海默病的发病机制及其研究进展中国临床康复[J], 8: 693.
邸秀珍,毕国华,孟海燕2007.吗啡依赖大鼠海马长时程增强改变及归元片的干预效应.中国药物依赖性杂志[J], 16: 266-270.
董丽萍,韩明,袁芳2007. I组mGluRs反义寡核苷酸抗谷氨酸对小鼠大脑皮层神经元的兴奋毒性作用.中国应用生理学杂志[J], 23: 438-440.
韩太真,吴馥梅1998.学习与记忆的神经生物学. [M].北京医科大学、中国协和大学联合出版社;北京.
胡前胜,任铁玲,傅洪军2004.低剂量铅对海马神经元神经细胞粘附因子表达的影响.中华预防医学杂志[J], 38: 379-382.
黄芬,李积胜,杨烽2004.慢性染铅大鼠皮层NOS和nNOS神经元的变化.武警医学[J],15: 573-575.
纪庆娥1994.选择性胆碱酯酶抑制剂-加兰他敏.国外医学合成药、生化药、制剂分册[J],15: 93.
江明性,杨藻宸1995.药理学（第四版）[M].人民卫生出版社;北京.
孔庆胜,王文军,李晶2009.儿童生长激素分泌水平及铁、锌、铅对其分泌量的影响.中华预防医学杂志[J], 43: 346.
雷荣辉,张进,易建华2003.铅接触仔鼠学习记忆行为与海马bcl-2和bax基因表达.工业卫生与职业病[J], 29: 226-229.
李峰,刘洋,焦莹2008.吗啡条件性位置偏爱大鼠脑伏核中CaMKⅡ及NOS阳性神经元变化.中国药物依赖性杂志[J]: 341-343.
李国君.,吴德生.,程薇波. 2000.铅对大鼠中枢神经系统中NOS的影响.现代预防医学[J],27: 449-452.
刘巧凤,金清华,申贤淑, et al. 2006.氨基酸对脑海马突触效应和学习记忆的影响.中国临床康复[J], 10: 2.
刘素媛,孙黎光,刑伟1999.慢性铅中毒对大鼠海马区神经细胞Ca2+浓度及Ca2+-ATP酶活性的影响.卫生毒理学杂志[J], 13: 16-21.
马广恩1998.加兰他敏治疗老年痴呆症的研究概况.药学进展[J], 22: 135.
梅镇彤1996.学习记忆的神经机制.生理科学进展[J], 27: 183-188.
阮迪云2001.铅对海马神经元通道、受体和递质的影响及其作用机制.广东微量元素科学[J], 8: 700-710.
唐竹吾,庞懿,张书琴1986.中枢神经系统解剖学[M].上海科学技术出版社;上海.
王晓燕,黄敏仁,韩正敏2004.石蒜属植物中加兰他敏的分离提取及其应用.南京林业大学学报：自然科学版[J], 28: 79-83.
王韵.,韩济生. 1999.一氧化氮在医学中的现在和将来.生理科学进展[J], 30: 94-95.
韦世秀,蒙子卿,叶峻2005.不同阶段海洛因成瘾大鼠脑内单胺递质的变化.中国医院药学杂志[J], 25: 396-398.
徐健,颜崇淮,沈晓明2004.海马代谢型谷氨酸受体与学习记忆的关系研究进展.中国儿童保健杂志[J], 12: 154-156.
徐健,袁崇淮,余晓刚2005.在体铅暴露对发育脑海马mGluR基因表达的影响.中华医学杂志[J], 85: 705-707.
叶翠飞,张兰,张丽2005.牛磺酸对东莨菪碱所致记忆性获得性障碍模型小鼠的改善作用.中国药理学通报[J], 21: 3.
叶智文,娄艾琳,郑华1988.老年大鼠的海马神经元对微量注射Ach的敏感性.生理科学进展[J], 8.
臧梦维,孟爱民,沈琦2000. NO-cGMP信号传导系统的上调参与阿片类药物耐受和戒断的生化机制.药学学报[J], 35: 566-570.
张亨山,赵西龙,宋丽华1997.铅对大鼠海马脑片谷氨酸递质体外释放的影响.中华预防医学杂志[J], 31: 285-287.
张建辉,庞广昌2006.阿片肽的研究进展与展望.食品科学[J], 27: 823-829.
张瑞岭,郝伟2004.慢性吗啡处理大鼠伏隔核、海马CA1区神经元突触界面结构改变.中华精神科杂志[J], 37: 187.
郑希耕,李勇辉,隋南2006.成瘾药物心理依赖及复发的脑机制研究.心理科学进展[J],14: 522-531.
周丽华,姚志彬,陈以慈1998.基底前脑解剖学及临床意义.神经解剖学杂志[J], 14:401-405.
ABE K, NAKATA A, MIZUTANI A, et al. 1994. Facilitatory but nonessential role of themuscarinic cholinergic system in the generation of long-term potentiation of populationspikes in the dentate gyrus in vivo. Neuropharmacology [J], 33: 847-852.
ABRAHAM W C, WICKENS J R 1991. Heterosynaptic long-term depression is facilitated byblockade of inhibition in area CA1 of the hippocampus. Brain Res [J], 546: 336-340.
ADAMS S V, WINTERER J, MULLER W 2004. Muscarinic signaling is required forspike-pairing induction of long-term potentiation at rat Schaffer collateral-CA1 synapses.Hippocampus [J], 14: 413-416.
ALBRIGHT T D, KANDEL E R, POSNER M I 2000. Cognitive neuroscience. Curr OpinNeurobiol [J], 10: 612-624.
ALES E, GULLO F, ARIAS E, et al. 2006. Blockade of Ca2+ -activated K+ channels bygalantamine can also contribute to the potentiation of catecholamine secretion fromchromaffin cells. Eur J Pharmacol [J], 548: 45-52.
ALGER B E, PITLER T A 1995. Retrograde signaling at GABAA-receptor synapses in themammalian CNS. Trends Neurosci [J], 18: 333-340.
ALGER B E, TEYLER T J 1976. Long-term and short-term plasticity in the CA1, CA3, anddentate regions of the rat hippocampal slice. Brain Res [J], 110: 463-480.
ALHEID G F, HEIMER L 1988. New perspectives in basal forebrain organization of specialrelevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, and corticopetalcomponents of substantia innominata. Neuroscience [J], 27: 1-39.
ALKONDON M, ALBUQUERQUE E X 2004. The nicotinic acetylcholine receptor subtypes andtheir function in the hippocampus and cerebral cortex. Prog Brain Res [J], 145: 109-120.
ALKONDON M, COSTA A C, RADHAKRISHNAN V, et al. 1990. Selective blockade ofNMDA-activated channel currents may be implicated in learning deficits caused by lead.FEBS Lett [J], 261: 124-130.
ALTMANN L, SVEINSSON K, WIEGAND H 1991. Long-term potentiation in rat hippocampalslices is impaired following acute lead perfusion. Neurosci Lett [J], 128: 109-112.
ALTMANN L, WEINSBERG F, SVEINSSON K, et al. 1993. Impairment of long-termpotentiation and learning following chronic lead exposure. Toxicol Lett [J], 66: 105-112.
AMUNDSEN T, NAESS I A, HAMMERSTROM J, et al. 2002. [Lead poisoning--an overview].Tidsskr Nor Laegeforen [J], 122: 1473-1476.
ANDERSEN P, SUNDBERG S H, SVEEN O, et al. 1977. Specific long-lasting potentiation ofsynaptic transmission in hippocampal slices. Nature [J], 266: 736-737.
ANDY O J, MITCHELL J 1960. The role of limbic structures in learned behavior. Surg Forum [J],11: 383-385.
ARIAS E, ALES E, GABILAN N H, et al. 2004. Galantamine prevents apoptosis induced bybeta-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors.Neuropharmacology [J], 46: 103-114.
ARON A R, SHOHAMY D, CLARK J, et al. 2004. Human midbrain sensitivity to cognitivefeedback and uncertainty during classification learning. J Neurophysiol [J], 92: 1144-1152.
ATCHISON W D, NARAHASHI T 1984. Mechanism of action of lead on neuromuscularjunctions. Neurotoxicology [J], 5: 267-282.
AUCLAIR A, DROUIN C, COTECCHIA S, et al. 2004. 5-HT2A and alpha1b-adrenergicreceptors entirely mediate dopamine release, locomotor response and behaviouralsensitization to opiates and psychostimulants. Eur J Neurosci [J], 20: 3073-3084.
AUDESIRK G 1987. Effects of in vitro and in vivo lead exposure on voltage-dependent calciumchannels in central neurons of Lymnaea stagnalis. Neurotoxicology [J], 8: 579-592.
AUDESIRK G, AUDESIRK T 1989. Effects of in vitro lead exposure on voltage-sensitive calciumchannels differ among cell types in central neurons of Lymnaea stagnalis. Neurotoxicology[J], 10: 659-669.
BAILEY C C, KITCHEN I 1986. Ontogeny of catecholamine and GABA levels in rat brain: lackof effect of perinatal lead exposure. Toxicol Lett [J], 30: 97-102.
BALSCHUN D, WOLFER D P, GASS P, et al. 2003. Does cAMP response element-bindingprotein have a pivotal role in hippocampal synaptic plasticity and hippocampus-dependentmemory? J Neurosci [J], 23: 6304-6314.
BAO J X, KANDEL E R, HAWKINS R D 1997. Involvement of pre- and postsynapticmechanisms in posttetanic potentiation at Aplysia synapses. Science [J], 275: 969-973.
BAO X, SHU S 1991. The stereotaxic atlas of the rat brain [M]. PEOPLES MEDICALPUBLISHING HOUSE; Beijing.
BARALDI M, ZANOLI P, ROSSI T, et al. 1985. Neurobehavioral and neurochemicalabnormalities of pre- and postnatally lead-exposed rats: zinc, copper and calcium status.Neurobehav Toxicol Teratol [J], 7: 499-509.
BARNES C A 1979. Memory deficits associated with senescence: a neurophysiological andbehavioral study in the rat. J Comp Physiol Psychol [J], 93: 74-104.
BARNES C A, MELTZER J, HOUSTON F, et al. 2000. Chronic treatment of old rats withdonepezil or galantamine: effects on memory, hippocampal plasticity and nicotinic receptors.Neuroscience [J], 99: 17-23.
BARR M L 1979. The human Nervous system：An Anatomic viewpoint. [M]. Harper&RowPublishers Inc.; Hagerstown.
BARRANTES G E, WESTWICK J, WONNACOTT S 1994. Nicotinic acetylcholine receptors inprimary cultures of hippocampal neurons: pharmacology and Ca++ permeability. BiochemSoc Trans [J], 22: 294S.
BASHA M R, WEI W, BAKHEET S A, et al. 2005. The fetal basis of amyloidogenesis: exposureto lead and latent overexpression of amyloid precursor protein and beta-amyloid in the agingbrain. J Neurosci [J], 25: 823-829.
BASHA M R, WEI W, BRYDIE M, et al. 2003. Lead-induced developmental perturbations inhippocampal Sp1 DNA-binding are prevented by zinc supplementation: in vivo evidence forPb and Zn competition. Int J Dev Neurosci [J], 21: 1-12.
BASKIN D S, BROWNING J L, PIROZZOLO F J, et al. 1999. Brain choline acetyltransferaseand mental function in Alzheimer disease. Arch Neurol [J], 56: 1121-1123.
BAXTER M G, BUCCI D J, GORMAN L K, et al. 1995. Selective immunotoxic lesions of basalforebrain cholinergic cells: effects on learning and memory in rats. Behav Neurosci [J], 109:714-722.
BEHL M, ZHANG Y, ZHENG W 2009. Involvement of insulin-degrading enzyme in theclearance of beta-amyloid at the blood-CSF barrier: Consequences of lead exposure.Cerebrospinal Fluid Res [J], 6: 11.
BEILHARZ E J, WILLIAMS C E, DRAGUNOW M, et al. 1995. Mechanisms of delayed celldeath following hypoxic-ischemic injury in the immature rat: evidence for apoptosis duringselective neuronal loss. Brain Res Mol Brain Res [J], 29: 1-14.
BELLUARDO N, MUDO G, BLUM M, et al. 2000. Central nicotinic receptors, neurotrophicfactors and neuroprotection. Behav Brain Res [J], 113: 21-34.
BEN-ARI Y, TREMBLAY E, OTTERSEN O P, et al. 1980. The role of epileptic activity inhippocampal and "remote" cerebral lesions induced by kainic acid. Brain Res [J], 191: 79-97.
BENARDO L S, PRINCE D A 1982. Cholinergic excitation of mammalian hippocampalpyramidal cells. Brain Res [J], 249: 315-331.
BENINGER R J, MILLER R 1998. Dopamine D1-like receptors and reward-related incentivelearning. Neurosci Biobehav Rev [J], 22: 335-345.
BENKE T A, LUTHI A, ISAAC J T, et al. 1998. Modulation of AMPA receptor unitaryconductance by synaptic activity. Nature [J], 393: 793-797.
BERG D K, CONROY W G 2002. Nicotinic alpha 7 receptors: synaptic options and downstreamsignaling in neurons. J Neurobiol [J], 53: 512-523.
BERGLUND M, AKESSON A, BJELLERUP P, et al. 2000. Metal-bone interactions. Toxicol Lett[J], 112-113: 219-225.
BERHOW M T, RUSSELL D S, TERWILLIGER R Z, et al. 1995. Influence of neurotrophicfactors on morphine- and cocaine-induced biochemical changes in the mesolimbic dopaminesystem. Neuroscience [J], 68: 969-979.
BIDLACK J M 2000. Detection and function of opioid receptors on cells from the immune system.Clin Diagn Lab Immunol [J], 7: 719-723.
BIGBEE J W, SHARMA K V, GUPTA J J, et al. 1999. Morphogenic role for acetylcholinesterasein axonal outgrowth during neural development. Environ Health Perspect [J], 107 Suppl 1:81-87.
BLAIR H T, SCHAFE G E, BAUER E P, et al. 2001. Synaptic plasticity in the lateral amygdala: acellular hypothesis of fear conditioning. Learn Mem [J], 8: 229-242.
BLISS T V, COLLINGRIDGE G L 1993. A synaptic model of memory: long-term potentiation inthe hippocampus. Nature [J], 361: 31-39.
BLISS T V, LOMO T 1973. Long-lasting potentiation of synaptic transmission in the dentate areaof the anaesthetized rabbit following stimulation of the perforant path. J Physiol [J], 232:331-356.
BOADA-ROVIRA M, BRODATY H, CRAS P, et al. 2004. Efficacy and safety of donepezil inpatients with Alzheimer's disease: results of a global, multinational, clinical experience study.Drugs Aging [J], 21: 43-53.
BOHUS B, URBAN I, VAN WIMERSMA GREIDANUS T B, et al. 1978. Opposite effects ofoxytocin and vasopressin on avoidance behaviour and hippocampal theta rhythm in the rat.Neuropharmacology [J], 17: 239-247.
BOISSIERE F, FAUCHEUX B, AGID Y, et al. 1997. Choline acetyltransferase mRNA expressionin the striatal neurons of patients with Alzheimer's disease. Neurosci Lett [J], 225: 169-172.
BOLIN C M, BASHA R, COX D, et al. 2006. Exposure to lead and the developmental origin ofoxidative DNA damage in the aging brain. FASEB J [J], 20: 788-790.
BONDY S C, HONG J S, TILSON H A, et al. 1985. Effects of triethyl lead on hot-plateresponsiveness and biochemical properties of hippocampus. Pharmacol Biochem Behav [J],22: 1007-1011.
BOUTON C M, FRELIN L P, FORDE C E, et al. 2001. Synaptotagmin I is a molecular target forlead. J Neurochem [J], 76: 1724-1735.
BRAGA M F, PEREIRA E F, MIKE A, et al. 2004. Pb2+ via protein kinase C inhibits nicotiniccholinergic modulation of synaptic transmission in the hippocampus. J Pharmacol Exp Ther[J], 311: 700-710.
BRAMHAM C R 1992. Opioid receptor dependent long-term potentiation: peptidergic regulationof synaptic plasticity in the hippocampus. Neurochem Int [J], 20: 441-455.
BRAMHAM C R, ERRINGTON M L, BLISS T V 1988. Naloxone blocks the induction oflong-term potentiation in the lateral but not in the medial perforant pathway in theanesthetized rat. Brain Res [J], 449: 352-356.
BRAMHAM C R, MILGRAM N W, SREBRO B 1991. Delta opioid receptor activation isrequired to induce LTP of synaptic transmission in the lateral perforant path in vivo. BrainRes [J], 567: 42-50.
BRAMHAM C R, SARVEY J M 1996. Endogenous activation of mu and delta-1 opioid receptorsis required for long-term potentiation induction in the lateral perforant path: dependence onGABAergic inhibition. J Neurosci [J], 16: 8123-8131.
BREDT D S, SNYDER S H 1992. Nitric oxide, a novel neuronal messenger. Neuron [J], 8: 3-11.
BUCHEL C, MORRIS J, DOLAN R J, et al. 1998. Brain systems mediating aversive conditioning:an event-related fMRI study. Neuron [J], 20: 947-957.
BUSSELBERG D, EVANS M L, RAHMANN H, et al. 1991. Lead and zinc block avoltage-activated calcium channel of Aplysia neurons. J Neurophysiol [J], 65: 786-795.
BUSSELBERG D, MICHAEL D, PLATT B 1994. Pb2+ reduces voltage- andN-methyl-D-aspartate (NMDA)-activated calcium channel currents. Cell Mol Neurobiol [J],14: 711-722.
CAJAL S 1911. Histologie du Systeme Nerveux de l'Homme et des Vertebretes [M]; Paris.
CALABRESI P, CENTONZE D, GUBELLINI P, et al. 1999. Glutamate-triggered events inducingcorticostriatal long-term depression. J Neurosci [J], 19: 6102-6110.
CALABRESI P, NAPOLITANO M, CENTONZE D, et al. 2000. Tissue plasminogen activatorcontrols multiple forms of synaptic plasticity and memory. Eur J Neurosci [J], 12: 1002-1012.
CANFIELD R L, HENDERSON C R, JR., CORY-SLECHTA D A, et al. 2003. Intellectualimpairment in children with blood lead concentrations below 10 microg per deciliter. N EnglJ Med [J], 348: 1517-1526.
CAPONE F, ADRIANI W, SHUMILINA M, et al. 2008. Autoantibodies against opioid orglutamate receptors are associated with changes in morphine reward and physicaldependence in mice. Psychopharmacology (Berl) [J], 197: 535-548.
CARICATI-NETO A, D'ANGELO L C, REUTER H, et al. 2004. Enhancement of purinergicneurotransmission by galantamine and other acetylcholinesterase inhibitors in the rat vasdeferens. Eur J Pharmacol [J], 503: 191-201.
CHAPMAN C R, TUCKETT R P, SONG C W 2008. Pain and stress in a systems perspective:reciprocal neural, endocrine, and immune interactions. J Pain [J], 9: 122-145.
CHEN L, HUANG L Y 1992. Protein kinase C reduces Mg2+ block of NMDA-receptor channelsas a mechanism of modulation. Nature [J], 356: 521-523.
CHEN Z, ITO K, FUJII S, et al. 1996. Roles of dopamine receptors in long-term depression:enhancement via D1 receptors and inhibition via D2 receptors. Receptors Channels [J], 4:1-8.
CHIAMULERA C, EPPING-JORDAN M P, ZOCCHI A, et al. 2001. Reinforcing and locomotorstimulant effects of cocaine are absent in mGluR5 null mutant mice. Nat Neurosci [J], 4:873-874.
CHOTINER J K, KHORASANI H, NAIRN A C, et al. 2003. Adenylyl cyclase-dependent form ofchemical long-term potentiation triggers translational regulation at the elongation step.Neuroscience [J], 116: 743-752.
CHRISTOFI G, NOWICKY A V, BOLSOVER S R, et al. 1993. The postsynaptic induction ofnonassociative long-term depression of excitatory synaptic transmission in rat hippocampalslices. J Neurophysiol [J], 69: 219-229.
COHN J, CORY-SLECHTA D A 1994. Assessment of the role of dopaminergic systems inlead-induced learning impairments using a repeated acquisition and performance baseline.Neurotoxicology [J], 15: 913-926.
COLEMAN B A, TAYLOR P 1996. Regulation of acetylcholinesterase expression duringneuronal differentiation. J Biol Chem [J], 271: 4410-4416.
COLINO A, HUANG Y Y, MALENKA R C 1992. Characterization of the integration time for thestabilization of long-term potentiation in area CA1 of the hippocampus. J Neurosci [J], 12:180-187.
COLLINGRIDGE G L, BLISS T V 1995. Memories of NMDA receptors and LTP. TrendsNeurosci [J], 18: 54-56.
COLLINGRIDGE G L, KEHL S J, MCLENNAN H 1983. Excitatory amino acids in synaptictransmission in the Schaffer collateral-commissural pathway of the rat hippocampus. JPhysiol [J], 334: 33-46.
COLLINGRIDGE G L, RANDALL A D, DAVIES C H, et al. 1992. The synaptic activation ofNMDA receptors and Ca2+ signalling in neurons. Ciba Found Symp [J], 164: 162-171;discussion 172-165.
CORDOVA F M, RODRIGUES A L, GIACOMELLI M B, et al. 2004. Lead stimulates ERK1/2and p38MAPK phosphorylation in the hippocampus of immature rats. Brain Res [J], 998:65-72.
CORY-SLECHTA D A 1995. Relationships between lead-induced learning impairments andchanges in dopaminergic, cholinergic, and glutamatergic neurotransmitter system functions.Annu Rev Pharmacol Toxicol [J], 35: 391-415.
CREMIN J D, JR., SMITH D R 2002. In vitro vs in vivo Pb effects on brain protein kinase Cactivity. Environ Res [J], 90: 191-199.
CUMMINGS J L 2004. Alzheimer's disease. N Engl J Med [J], 351: 56-67.
DAJAS-BAILADOR F A, HEIMALA K, WONNACOTT S 2003. The allosteric potentiation ofnicotinic acetylcholine receptors by galantamine is transduced into cellular responses inneurons: Ca2+ signals and neurotransmitter release. Mol Pharmacol [J], 64: 1217-1226.
DAMASIO A R 1989. Time-locked multiregional retroactivation: a systems-level proposal for theneural substrates of recall and recognition. Cognition [J], 33: 25-62.
DAMASIO A R, TRANEL D, DAMASIO H 1989. Handbook of Neuropsychology [M]. Elsevier;Amsterdam.
DAVIES P, TERRY R D 1981. Cortical somatostatin-like immunoreactivity in cases ofAlzheimer's disease and senile dementia of the Alzheimer type. Neurobiol Aging [J], 2: 9-14.
DAVIS J M, ELIAS R W, GRANT L D 1993. Current issues in human lead exposure andregulation of lead. Neurotoxicology [J], 14: 15-27.
DE ROVER M, LODDER J C, SCHOFFELMEER A N, et al. 2005. Intermittent morphinetreatment induces a long-lasting increase in cholinergic modulation of GABAergic synapsesin nucleus accumbens of adult rats. Synapse [J], 55: 17-25.
DENG W, PORETZ R D 2002. Protein kinase C activation is required for the lead-inducedinhibition of proliferation and differentiation of cultured oligodendroglial progenitor cells.Brain Res [J], 929: 87-95.
DESMOND N L, COLBERT C M, ZHANG D X, et al. 1991. NMDA receptor antagonists blockthe induction of long-term depression in the hippocampal dentate gyrus of the anesthetizedrat. Brain Res [J], 552: 93-98.
DESMOND N L, LEVY W B 1983. Synaptic correlates of associative potentiation/depression: anultrastructural study in the hippocampus. Brain Res [J], 265: 21-30.
DHAWAN B N, CESSELIN F, RAGHUBIR R, et al. 1996. International Union of Pharmacology.XII. Classification of opioid receptors. Pharmacol Rev [J], 48: 567-592.
DIETRICH K N, WARE J H, SALGANIK M, et al. 2004. Effect of chelation therapy on theneuropsychological and behavioral development of lead-exposed children after school entry.Pediatrics [J], 114: 19-26.
DO V H, MARTINEZ C O, MARTINEZ J L, JR., et al. 2002. Long-term potentiation in directperforant path projections to the hippocampal CA3 region in vivo. J Neurophysiol [J], 87:669-678.
DONG H, XIANG Y Y, FARCHI N, et al. 2004. Excessive expression of acetylcholinesteraseimpairs glutamatergic synaptogenesis in hippocampal neurons. J Neurosci [J], 24:8950-8960.
DONG J, YIN H, LIU W, et al. 2005. Congenital iodine deficiency and hypothyroidism impairLTP and decrease C-fos and C-jun expression in rat hippocampus. Neurotoxicology [J], 26:417-426.
DORI A, IFERGANE G, SAAR-LEVY T, et al. 2007. Readthrough acetylcholinesterase ininflammation-associated neuropathies. Life Sci [J], 80: 2369-2374.
DRAGUNOW M, ABRAHAM W C, GOULDING M, et al. 1989. Long-term potentiation and theinduction of c-fos mRNA and proteins in the dentate gyrus of unanesthetized rats. NeurosciLett [J], 101: 274-280.
DRAKE C T, CHAVKIN C, MILNER T A 2007. Opioid systems in the dentate gyrus. Prog BrainRes [J], 163: 245-263.
DRAKE C T, MILNER T A 1999. Mu opioid receptors are in somatodendritic and axonalcompartments of GABAergic neurons in rat hippocampal formation. Brain Res [J], 849:203-215.
DUDAI Y 1989. The neurobiology and memory:Concepts,findings,trends. [M]. Oxford UniversityPress; Oxford.
DUDEK S M, BEAR M F 1993. Bidirectional long-term modification of synaptic effectiveness inthe adult and immature hippocampus. J Neurosci [J], 13: 2910-2918.
DUNBAR G L, RYLETT R J, SCHMIDT B M, et al. 1993. Hippocampal cholineacetyltransferase activity correlates with spatial learning in aged rats. Brain Res [J], 604:266-272.
DUNWIDDIE T, LYNCH G 1978. Long-term potentiation and depression of synaptic responses inthe rat hippocampus: localization and frequency dependency. J Physiol [J], 276: 353-367.
EAGGER S A, LEVY R, SAHAKIAN B J 1991. Tacrine in Alzheimer's disease. Lancet [J], 337:989-992.
ECCLES J C, KRNJEVIC K 1959. Presynaptic changes associated with post-tetanic potentiationin the spinal cord. J Physiol [J], 149: 274-287.
ECCLES J C, RALL W 1950. Post-tetanic potentiation of responses of motoneurones. Nature [J],166: 465-466.
ELLIS M R, KANE K Y 2000. Lightening the lead load in children. Am Fam Physician [J], 62:545-554, 559-560.
ENSMINGER M E, ANTHONY J C, MCCORD J 1997. The inner city and drug use: initialfindings from an epidemiological study. Drug Alcohol Depend [J], 48: 175-184.
ERNFORS P, BRAMHAM C R 2003. The coupling of a trkB tyrosine residue to LTP. TrendsNeurosci [J], 26: 171-173.
EZOULIN M J, OMBETTA J E, DUTERTRE-CATELLA H, et al. 2008. Antioxidative propertiesof galantamine on neuronal damage induced by hydrogen peroxide in SK-N-SH cells.Neurotoxicology [J], 29: 270-277.
FABIAN-FINE R, SKEHEL P, ERRINGTON M L, et al. 2001. Ultrastructural distribution of thealpha7 nicotinic acetylcholine receptor subunit in rat hippocampus. J Neurosci [J], 21:7993-8003.
FEDER R, RANCK J B, JR. 1973. Studies on single neurons in dorsal hippocampal formation andseptum in unrestrained rats. II. Hippocampal slow waves and theta cell firing during barpressing and other behaviors. Exp Neurol [J], 41: 532-555.
FICHNA J, JANECKA A, PIESTRZENIEWICZ M, et al. 2007. Antidepressant-like effect ofendomorphin-1 and endomorphin-2 in mice. Neuropsychopharmacology [J], 32: 813-821.
FLORA S J, TANDON S K 1986. Preventive and therapeutic effects of thiamine, ascorbic acidand their combination in lead intoxication. Acta Pharmacol Toxicol (Copenh) [J], 58:374-378.
FORD D H, RHINES R K 1979. Prenatal exposure to methadone HCL in relationship to body andbrain growth in the rat. Acta Neurol Scand [J], 59: 248-262.
FUJII S, JI Z, MORITA N, et al. 1999. Acute and chronic nicotine exposure differentially facilitatethe induction of LTP. Brain Res [J], 846: 137-143.
FUKUNAGA K, MULLER D, MIYAMOTO E 1995. Increased phosphorylation ofCa2+/calmodulin-dependent protein kinase II and its endogenous substrates in the inductionof long-term potentiation. J Biol Chem [J], 270: 6119-6124.
FULLMER C S, EDELSTEIN S, WASSERMAN R H 1985. Lead-binding properties of intestinalcalcium-binding proteins. J Biol Chem [J], 260: 6816-6819.
GARZA A, VEGA R, SOTO E 2006. Cellular mechanisms of lead neurotoxicity. Med Sci Monit[J], 12: RA57-65.
GE S, DANI J A 2005. Nicotinic acetylcholine receptors at glutamate synapses facilitate long-termdepression or potentiation. J Neurosci [J], 25: 6084-6091.
GEDEON Y, RAMESH G T, WELLMAN P J, et al. 2001. Changes in mesocorticolimbicdopamine and D1/D2 receptor levels after low level lead exposure: a time course study.Toxicol Lett [J], 123: 217-226.
GETOVA D P, BOWERY N G 2001. Effects of high-affinity GABAB receptor antagonists onactive and passive avoidance responding in rodents withgamma-hydroxybutyrolactone-induced absence syndrome. Psychopharmacology (Berl) [J],157: 89-95.
GHELARDINI C, GALEOTTI N, MATUCCI R, et al. 1999. Antisense 'knockdowns' of M1receptors induces transient anterograde amnesia in mice. Neuropharmacology [J], 38:339-348.
GIACOBINI E 1998. Cholinergic foundations of Alzheimer's disease therapy. J Physiol Paris [J],92: 283-287.
GILBERT M E, LASLEY S M 2002. Long-term consequences of developmental exposure to leador polychlorinated biphenyls: Synaptic transmission and plasticity in the rodent CNS.Environ Toxicol Pharmacol [J], 12: 105-117.
GILBERT M E, MACK C M, LASLEY S M 1996. Chronic developmental lead exposureincreases the threshold for long-term potentiation in rat dentate gyrus in vivo. Brain Res [J],736: 118-124.
GILBOA-GEFFEN A, LACOSTE P P, SOREQ L, et al. 2007. The thymic theme ofacetylcholinesterase splice variants in myasthenia gravis. Blood [J], 109: 4383-4391.
GILL K D, GUPTA V, SANDHIR R 2003. Ca2+/calmodulin-mediated neurotransmitter releaseand neurobehavioural deficits following lead exposure. Cell Biochem Funct [J], 21: 345-353.
GIORGETTI M, BACCIOTTINI L, GIOVANNINI M G, et al. 2000. Local GABAergicmodulation of acetylcholine release from the cortex of freely moving rats. Eur J Neurosci [J],12: 1941-1948.
GODWIN H A 2001. The biological chemistry of lead. Curr Opin Chem Biol [J], 5: 223-227.
GOEBEL S M, ALVESTAD R M, COULTRAP S J, et al. 2005. Tyrosine phosphorylation of theN-methyl-D-aspartate receptor is enhanced in synaptic membrane fractions of the adult rathippocampus. Brain Res Mol Brain Res [J], 142: 65-79.
GOLDBERG I E, ROSSI G C, LETCHWORTH S R, et al. 1998. Pharmacologicalcharacterization of endomorphin-1 and endomorphin-2 in mouse brain. J Pharmacol ExpTher [J], 286: 1007-1013.
GONG Y X, LV M, ZHU Y P, et al. 2007. Endogenous histamine inhibits the development ofmorphine-induced conditioned place preference. Acta Pharmacol Sin [J], 28: 10-18.
GORDON J N, TAYLOR A, BENNETT P N 2002. Lead poisoning: case studies. Br J ClinPharmacol [J], 53: 451-458.
GRAZIANO J, SLAVKOVICH V, LIU X, et al. 2004. A prospective study of prenatal andchildhood lead exposure and erythropoietin production. J Occup Environ Med [J], 46:924-929.
GRUART A, MUNOZ M D, DELGADO-GARCIA J M 2006. Involvement of the CA3-CA1synapse in the acquisition of associative learning in behaving mice. J Neurosci [J], 26:1077-1087.
GUAN Z Z, ZHANG X, RAVID R, et al. 2000. Decreased protein levels of nicotinic receptorsubunits in the hippocampus and temporal cortex of patients with Alzheimer's disease. JNeurochem [J], 74: 237-243.
GUILARTE T R, MCGLOTHAN J L 1998. Hippocampal NMDA receptor mRNA undergoessubunit specific changes during developmental lead exposure. Brain Res [J], 790: 98-107.
GUILARTE T R, MICELI R C 1992. Age-dependent effects of lead on [3H]MK-801 binding tothe NMDA receptor-gated ionophore: in vitro and in vivo studies. Neurosci Lett [J], 148:27-30.
GUILARTE T R, MICELI R C, JETT D A 1995. Biochemical evidence of an interaction of lead atthe zinc allosteric sites of the NMDA receptor complex: effects of neuronal development.Neurotoxicology [J], 16: 63-71.
GUO N, GARCIA M M, HARLAN R E 2008. A morphine-paired environment alters c-Fosexpression in the forebrain of rats displaying conditioned place preference or aversion. BehavNeurosci [J], 122: 1078-1086.
GURER H, OZGUNES H, NEAL R, et al. 1998. Antioxidant effects of N-acetylcysteine andsuccimer in red blood cells from lead-exposed rats. Toxicology [J], 128: 181-189.
HABERMANN E, CROWELL K, JANICKI P 1983. Lead and other metals can substitute forCa2+ in calmodulin. Arch Toxicol [J], 54: 61-70.
HANAFY S, SOLTAN M E 2004. Effects of Vitamin E pretreatment on subacute toxicity ofmixture of Co, Pb, and Hg nitrate-induced nephrotoxicity in rats. Environ Toxicol Pharmacol[J], 17: 159-167.
HANDELMANN G E, OLTON D S 1981. Spatial memory following damage to hippocampalCA3 pyramidal cells with kainic acid: impairment and recovery with preoperative training.Brain Res [J], 217: 41-58.
HANNAY T, LARKMAN A, STRATFORD K, et al. 1993. A common rule governs the synapticlocus of both short-term and long-term potentiation. Curr Biol [J], 3: 832-841.
HARTGRAVES S L, MENSAH P L, KELLY P H 1982. Regional decreases of cortical cholineacetyltransferase after lesions of the septal area and in the area of nucleus basalismagnocellularis. Neuroscience [J], 7: 2369-2376.
HARWELL T S, SPENCE M R, SANDS A, et al. 1996. Substance use in an inner-city familyplanning population. J Reprod Med [J], 41: 704-710.
HE S Q, ZHANG Z N, GUAN J S, et al. 2011. Facilitation of mu-opioid receptor activity bypreventing delta-opioid receptor-mediated codegradation. Neuron [J], 69: 120-131.
HEFTI F, DRAVID A, HARTIKKA J 1984. Chronic intraventricular injections of nerve growthfactor elevate hippocampal choline acetyltransferase activity in adult rats with partialsepto-hippocampal lesions. Brain Res [J], 293: 305-311.
HERROLD A A, SHEN F, GRAHAM M P, et al. 2009. Mirtazapine treatment after conditioningwith methamphetamine alters subsequent expression of place preference. Drug AlcoholDepend [J], 99: 231-239.
HESS D T, LIN L H, FREEMAN J A, et al. 1994. Modification of cysteine residues within G(o)and other neuronal proteins by exposure to nitric oxide. Neuropharmacology [J], 33:1283-1292.
HINOI E, BALCAR V J, KURAMOTO N, et al. 2002. Nuclear transcription factors in thehippocampus. Prog Neurobiol [J], 68: 145-165.
HUANG F, SCHNEIDER J S 2004. Effects of lead exposure on proliferation and differentiation ofneural stem cells derived from different regions of embryonic rat brain. Neurotoxicology [J],25: 1001-1012.
HUANG M, KREPKIY D, HU W, et al. 2004. Zn-, Cd-, and Pb-transcription factor IIIA:properties, DNA binding, and comparison with TFIIIA-finger 3 metal complexes. J InorgBiochem [J], 98: 775-785.
HUDA W, RILL L N, BENN D K, et al. 1997. Comparison of a photostimulable phosphor systemwith film for dental radiology. Oral Surg Oral Med Oral Pathol Oral Radiol Endod [J], 83:725-731.
HUSSAIN R J, PARSONS P J, CARPENTER D O 2000. Effects of lead on long-term potentiationin hippocampal CA3 vary with age. Brain Res Dev Brain Res [J], 121: 243-252.
IARUSHKIN V 1992. [Heavy metals in the mother-newborn infant biological system in thetechnology-related biogeochemical environment]. Gig Sanit [J]: 13-15.
IGA Y, ARISAWA H, ISE M, et al. 1996. Modulation of rhythmical slow activity, long-termpotentiation and memory by muscarinic receptor agonists. Eur J Pharmacol [J], 308: 13-19.
IKONOMIDOU C, BOSCH F, MIKSA M, et al. 1999. Blockade of NMDA receptors andapoptotic neurodegeneration in the developing brain. Science [J], 283: 70-74.
ISAAC J T, LUTHI A, PALMER M J, et al. 1998. An investigation of the expression mechanismof LTP of AMPA receptor-mediated synaptic transmission at hippocampal CA1 synapsesusing failures analysis and dendritic recordings. Neuropharmacology [J], 37: 1399-1410.
ITO M, SAKURAI M, TONGROACH P 1982. Climbing fibre induced depression of both mossyfibre responsiveness and glutamate sensitivity of cerebellar Purkinje cells. J Physiol [J], 324:113-134.
ITO Y, NIIYA Y, KURITA H, et al. 1985. Serum lipid peroxide level and blood superoxidedismutase activity in workers with occupational exposure to lead. Int Arch Occup EnvironHealth [J], 56: 119-127.
JANECKA A, FICHNA J, JANECKI T 2004. Opioid receptors and their ligands. Curr Top MedChem [J], 4: 1-17.
JANN M W 2000. Rivastigmine, a new-generation cholinesterase inhibitor for the treatment ofAlzheimer's disease. Pharmacotherapy [J], 20: 1-12.
JELLIFFE-PAWLOWSKI L L, MILES S Q, COURTNEY J G, et al. 2006. Effect of magnitudeand timing of maternal pregnancy blood lead (Pb) levels on birth outcomes. J Perinatol [J],26: 154-162.
JENTSCH J D, TAYLOR J R 1999. Impulsivity resulting from frontostriatal dysfunction in drugabuse: implications for the control of behavior by reward-related stimuli.Psychopharmacology (Berl) [J], 146: 373-390.
JI D, LAPE R, DANI J A 2001. Timing and location of nicotinic activity enhances or depresseshippocampal synaptic plasticity. Neuron [J], 31: 131-141.
JI X, LI C, LU Y, et al. 2007. Post-ischemic continuous administration of galantamine attenuatescognitive deficits and hippocampal neurons loss after transient global ischemia in gerbils.Neurosci Lett [J], 416: 92-95.
JIN-CHENG L, WEN Y, ZHAO Y, et al. 2008. Anti-arrhythmic effects of kappa-opioid receptorand its changes in ischemia and reperfusion. Arch Med Res [J], 39: 483-488.
JIN W, LEE N M, LOH H H, et al. 1992. Dual excitatory and inhibitory effects of opioids onintracellular calcium in neuroblastoma x glioma hybrid NG108-15 cells. Mol Pharmacol [J],42: 1083-1089.
JOHNSTON D, WILLIAMS S, JAFFE D, et al. 1992. NMDA-receptor-independent long-termpotentiation. Annu Rev Physiol [J], 54: 489-505.
JONES S, SUDWEEKS S, YAKEL J L 1999. Nicotinic receptors in the brain: correlatingphysiology with function. Trends Neurosci [J], 22: 555-561.
JOSSELYN S A, NGUYEN P V 2005. CREB, synapses and memory disorders: past progress andfuture challenges. Curr Drug Targets CNS Neurol Disord [J], 4: 481-497.
JUSKO T A, HENDERSON C R, LANPHEAR B P, et al. 2008. Blood lead concentrations < 10microg/dL and child intelligence at 6 years of age. Environ Health Perspect [J], 116: 243-248.
KACZOR A, MATOSIUK D 2002. Non-peptide opioid receptor ligands - recent advances. Part II- antagonists. Curr Med Chem [J], 9: 1591-1603.
KALIVAS P W 1993. Neurotransmitter regulation of dopamine neurons in the ventral tegmentalarea. Brain Res Brain Res Rev [J], 18: 75-113.
KASA P, RAKONCZAY Z, GULYA K 1997. The cholinergic system in Alzheimer's disease. ProgNeurobiol [J], 52: 511-535.
KATO N, YOSHIMURA H 1993. Tetanization during GABAA receptor activation induceslong-term depression in visual cortex slices. Neuropharmacology [J], 32: 511-513.
KERN M, WISNIEWSKI M, CABELL L, et al. 2000. Inorganic lead and calcium interactpositively in activation of calmodulin. Neurotoxicology [J], 21: 353-363.
KHACHATURIAN Z S 1984. Scientific challenges and opportunities related to Alzheimer'sdisease. Clin Pharm [J], 3: 522-523.
KIEDROWSKI L 2007. Critical role of sodium in cytosolic [Ca2+] elevations in culturedhippocampal CA1 neurons during anoxic depolarization. J Neurochem [J], 100: 915-923.
KIHARA T, SAWADA H, NAKAMIZO T, et al. 2004. Galantamine modulates nicotinic receptorand blocks Abeta-enhanced glutamate toxicity. Biochem Biophys Res Commun [J], 325:976-982.
KITCHEN I 1993. Lead toxicity and alterations in opioid systems. Neurotoxicology [J], 14:115-124.
KITCHEN I, MCDOWELL J, WINDER C, et al. 1984. Low-level lead exposure alters morphineantinociception in neonatal rats. Toxicol Lett [J], 22: 119-123.
KLECKNER N W, DINGLEDINE R 1988. Requirement for glycine in activation of
NMDA-receptors expressed in Xenopus oocytes. Science [J], 241: 835-837.
KLEIN M, SHAPIRO E, KANDEL E R 1980. Synaptic plasticity and the modulation of the Ca2+current. J Exp Biol [J], 89: 117-157.
KOIKE S 1997. [Low-level lead exposure and children's intelligence from recent epidemiologicalstudies in the U.S.A. and other countries to progress in reducing lead exposure and screeningin the U.S.A]. Nihon Eiseigaku Zasshi [J], 52: 552-561.
KOOB G F, MALDONADO R, STINUS L 1992. Neural substrates of opiate withdrawal. TrendsNeurosci [J], 15: 186-191.
KRIEGER D T 1983. Brain peptides: what, where, and why? Science [J], 222: 975-985.
KRNJEVIC K, REIFFENSTEIN R J, ROPERT N 1981. Disinhibitory action of acetylcholine inthe rat's hippocampus: extracellular observations. Neuroscience [J], 6: 2465-2474.
KRYGER G, SILMAN I, SUSSMAN J L 1999. Structure of acetylcholinesterase complexed withE2020 (Aricept): implications for the design of new anti-Alzheimer drugs. Structure [J], 7:297-307.
KUFAHL P R, ZAVALA A R, SINGH A, et al. 2009. c-Fos expression associated withreinstatement of cocaine-seeking behavior by response-contingent conditioned cues. Synapse[J], 63: 823-835.
KUMAR A, ZOU L, YUAN X, et al. 2002. N-methyl-D-aspartate receptors: transient loss ofNR1/NR2A/NR2B subunits after traumatic brain injury in a rodent model. J Neurosci Res [J],67: 781-786.
LACHOWICZ J E, DUFFY R A, RUPERTO V, et al. 2001. Facilitation of acetylcholine releaseand improvement in cognition by a selective M2 muscarinic antagonist, SCH 72788. Life Sci[J], 68: 2585-2592.
LAFOND J, HAMEL A, TAKSER L, et al. 2004. Low environmental contamination by lead inpregnant women: effect on calcium transfer in human placental syncytiotrophoblasts. JToxicol Environ Health A [J], 67: 1069-1079.
LANE-LADD S B, PINEDA J, BOUNDY V A, et al. 1997. CREB (cAMP responseelement-binding protein) in the locus coeruleus: biochemical, physiological, and behavioralevidence for a role in opiate dependence. J Neurosci [J], 17: 7890-7901.
LASLEY S M, GILBERT M E 1996. Presynaptic glutamatergic function in dentate gyrus in vivois diminished by chronic exposure to inorganic lead. Brain Res [J], 736: 125-134.
LASLEY S M, GILBERT M E 1999. Lead inhibits the rat N-methyl-d-aspartate receptor channelby binding to a site distinct from the zinc allosteric site. Toxicol Appl Pharmacol [J], 159:224-233.
LASLEY S M, GILBERT M E 2000. Glutamatergic components underlying lead-inducedimpairments in hippocampal synaptic plasticity. Neurotoxicology [J], 21: 1057-1068.
LAW P Y, WU J, KOEHLER J E, et al. 1981. Demonstration and characterization of opiateinhibition of the striatal adenylate cyclase. J Neurochem [J], 36: 1834-1846.
LEGROS J J, GILOT P, SERON X, et al. 1978. Influence of vasopressin on learning and memory.Lancet [J], 1: 41-42.
LEONARD A S, LIM I A, HEMSWORTH D E, et al. 1999. Calcium/calmodulin-dependentprotein kinase II is associated with the N-methyl-D-aspartate receptor. Proc Natl Acad Sci US A [J], 96: 3239-3244.
LEUNG L S, FU X W 1994. Factors affecting paired-pulse facilitation in hippocampal CA1neurons in vitro. Brain Res [J], 650: 75-84.
LI C, XING T, TANG M, et al. 2008a. Involvement of cyclin D1/CDK4 and pRb mediated byPI3K/AKT pathway activation in Pb2+ -induced neuronal death in cultured hippocampalneurons. Toxicol Appl Pharmacol [J], 229: 351-361.
LI S X, WANG Z R, LI J, et al. 2008b. Inhibition of Period1 gene attenuates themorphine-induced ERK-CREB activation in frontal cortex, hippocampus, and striatum inmice. Am J Drug Alcohol Abuse [J], 34: 673-682.
LI Y Q, LI F Q, WANG X Y, et al. 2008c. Central amygdala extracellular signal-regulated kinasesignaling pathway is critical to incubation of opiate craving. J Neurosci [J], 28: 13248-13257.
LINDAHL L S, BIRD L, LEGARE M E, et al. 1999. Differential ability of astroglia and neuronalcells to accumulate lead: dependence on cell type and on degree of differentiation. ToxicolSci [J], 50: 236-243.
LINDEN D J, CONNOR J A 1995. Long-term synaptic depression. Annu Rev Neurosci [J], 18:319-357.
LINDEN D J, SMEYNE M, CONNOR J A 1993. Induction of cerebellar long-term depression inculture requires postsynaptic action of sodium ions. Neuron [J], 11: 1093-1100.
LIU J, HAN D, LI Y, et al. 2010. Lead affects apoptosis and related gene XIAP and Smacexpression in the hippocampus of developing rats. Neurochem Res [J], 35: 473-479.
LOH H H, LIU H C, CAVALLI A, et al. 1998. mu Opioid receptor knockout in mice: effects onligand-induced analgesia and morphine lethality. Brain Res Mol Brain Res [J], 54: 321-326.
LOPEZ O L, HAMILTON R L, BECKER J T, et al. 2000. Severity of cognitive impairment andthe clinical diagnosis of AD with Lewy bodies. Neurology [J], 54: 1780-1787.
LORRIO S, SOBRADO M, ARIAS E, et al. 2007. Galantamine postischemia providesneuroprotection and memory recovery against transient global cerebral ischemia in gerbils. JPharmacol Exp Ther [J], 322: 591-599.
LOVEMAN E, GREEN C, KIRBY J, et al. 2006. The clinical and cost-effectiveness of donepezil,rivastigmine, galantamine and memantine for Alzheimer's disease. Health Technol Assess [J],10: iii-iv, ix-xi, 1-160.
LOVINGER D M, WONG K L, MURAKAMI K, et al. 1987. Protein kinase C inhibitorseliminate hippocampal long-term potentiation. Brain Res [J], 436: 177-183.
LU G, ZHOU Q X, KANG S, et al. 2010. Chronic morphine treatment impaired hippocampallong-term potentiation and spatial memory via accumulation of extracellular adenosine actingon adenosine A1 receptors. J Neurosci [J], 30: 5058-5070.
LUKAS R J, BENCHERIF M 1992. Heterogeneity and regulation of nicotinic acetylcholinereceptors. Int Rev Neurobiol [J], 34: 25-131.
LUO X, WEBER G A, ZHENG J, et al. 2003. C1q-calreticulin induced oxidative neurotoxicity:relevance for the neuropathogenesis of Alzheimer's disease. J Neuroimmunol [J], 135: 62-71.
MA H Y, LI H 2006. Kinds of heavy metal and placental barriers. Chin J Ind Hyg Occup Dis [J], 1:44.
MA Y Y, GUO C Y, YU P, et al. 2006. The role of NR2B containing NMDA receptor in placepreference conditioned with morphine and natural reinforcers in rats. Exp Neurol [J], 200:343-355.
MAELICKE A, ALBUQUERQUE E X 2000. Allosteric modulation of nicotinic acetylcholinereceptors as a treatment strategy for Alzheimer's disease. Eur J Pharmacol [J], 393: 165-170.
MAELICKE A, SAMOCHOCKI M, JOSTOCK R, et al. 2001. Allosteric sensitization of nicotinicreceptors by galantamine, a new treatment strategy for Alzheimer's disease. Biol Psychiatry[J], 49: 279-288.
MAGUIRE E A, BURGESS N, DONNETT J G, et al. 1998. Knowing where and getting there: ahuman navigation network. Science [J], 280: 921-924.
MALENKA R C, KAUER J A, PERKEL D J, et al. 1989. An essential role for postsynapticcalmodulin and protein kinase activity in long-term potentiation. Nature [J], 340: 554-557.
MALENKA R C, NICOLL R A 1999. Long-term potentiation--a decade of progress? Science [J],285: 1870-1874.
MALINOW R, MALENKA R C 2002. AMPA receptor trafficking and synaptic plasticity. AnnuRev Neurosci [J], 25: 103-126.
MANSOURI F A, MOTAMEDI F, FATHOLLAHI Y 1999. Chronic in vivo morphineadministration facilitates primed-bursts-induced long-term potentiation of Schaffercollateral-CA1 synapses in hippocampal slices in vitro. Brain Res [J], 815: 419-423.
MAO J, PRICE D D, MAYER D J 1995. Mechanisms of hyperalgesia and morphine tolerance: acurrent view of their possible interactions. Pain [J], 62: 259-274.
MARCO-CONTELLES J, DO CARMO CARREIRAS M, RODRIGUEZ C, et al. 2006. Synthesisand pharmacology of galantamine. Chem Rev [J], 106: 116-133.
MARECEK J, SHAPIRO I M, BURKE A, et al. 1983. Low-level lead exposure in childhoodinfluences neuropsychological performance. Arch Environ Health [J], 38: 355-359.
MARKOVAC J, GOLDSTEIN G W 1988. Picomolar concentrations of lead stimulate brainprotein kinase C. Nature [J], 334: 71-73.
MATSUO R, ASADA A, FUJITANI K, et al. 2001. LIRF, a gene induced during hippocampallong-term potentiation as an immediate-early gene, encodes a novel RING finger protein.Biochem Biophys Res Commun [J], 289: 479-484.
MATSUO R, MURAYAMA A, SAITOH Y, et al. 2000. Identification and cataloging of genesinduced by long-lasting long-term potentiation in awake rats. J Neurochem [J], 74:2239-2249.
MATTHES H W, MALDONADO R, SIMONIN F, et al. 1996. Loss of morphine-inducedanalgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptorgene. Nature [J], 383: 819-823.
MATTHES H W, SMADJA C, VALVERDE O, et al. 1998. Activity of the delta-opioid receptor ispartially reduced, whereas activity of the kappa-receptor is maintained in mice lacking themu-receptor. J Neurosci [J], 18: 7285-7295.
MATTHIES H, SCHROEDER H, BECKER A, et al. 2000. Lack of expression of long-termpotentiation in the dentate gyrus but not in the CA1 region of the hippocampus of mu-opioidreceptor-deficient mice. Neuropharmacology [J], 39: 952-960.
MAYER J H, STEFFENSEN S C, HENRIKSEN S J 1995. Site-selective acute desensitizationfollowing local administration of opioid in the hippocampus. Brain Res [J], 686: 134-142.
MCBRIDE W J, MURPHY J M, IKEMOTO S 1999. Localization of brain reinforcementmechanisms: intracranial self-administration and intracranial place-conditioning studies.Behav Brain Res [J], 101: 129-152.
MCDOWELL J, KITCHEN I 1988. Perinatal lead exposure alters the development of delta- butnot mu-opioid receptors in rat brain. Br J Pharmacol [J], 94: 933-937.
MELO J B, SOUSA C, GARCAO P, et al. 2009. Galantamine protects against oxidative stressinduced by amyloid-beta peptide in cortical neurons. Eur J Neurosci [J], 29: 455-464.
MENDOLA P, SELEVAN S G, GUTTER S, et al. 2002. Environmental factors associated with aspectrum of neurodevelopmental deficits. Ment Retard Dev Disabil Res Rev [J], 8: 188-197.
MIHAILOVA D, YAMBOLIEV I, ZHIVKOVA Z, et al. 1989. Pharmacokinetics of galanthaminehydrobromide after single subcutaneous and oral dosage in humans. Pharmacology [J], 39:50-58.
MIKE A, PEREIRA E F, ALBUQUERQUE E X 2000. Ca(2+)-sensitive inhibition by Pb(2+) ofalpha7-containing nicotinic acetylcholine receptors in hippocampal neurons. Brain Res [J],873: 112-123.
MILLAN M J 1990. Kappa-opioid receptors and analgesia. Trends Pharmacol Sci [J], 11: 70-76.
MILLER D K, NATION J R, JOST T E, et al. 2000. Differential effects of adult and perinatal leadexposure on morphine-induced locomotor activity in rats. Pharmacol Biochem Behav [J], 67:281-290.
MIYAKAWA T, YAMADA M, DUTTAROY A, et al. 2001. Hyperactivity and intacthippocampus-dependent learning in mice lacking the M1 muscarinic acetylcholine receptor. JNeurosci [J], 21: 5239-5250.
MIYAMOTO E 2006. Molecular mechanism of neuronal plasticity: induction and maintenance oflong-term potentiation in the hippocampus. J Pharmacol Sci [J], 100: 433-442.
MIYAMOTO M, KATO J, NARUMI S, et al. 1987. Characteristics of memory impairmentfollowing lesioning of the basal forebrain and medial septal nucleus in rats. Brain Res [J],419: 19-31.
MIYAMOTO M, NARUMI S, NAGAOKA A, et al. 1989. Effects of continuous infusion ofcholinergic drugs on memory impairment in rats with basal forebrain lesions. J PharmacolExp Ther [J], 248: 825-835.
MIYAMOTO M, SHINTANI M, NAGAOKA A, et al. 1985. Lesioning of the rat basal forebrainleads to memory impairments in passive and active avoidance tasks. Brain Res [J], 328:97-104.
MIZOGUCHI H, NARITA M, OJI D E, et al. 1999. The mu-opioid receptor gene-dose dependentreductions in G-protein activation in the pons/medulla and antinociception induced byendomorphins in mu-opioid receptor knockout mice. Neuroscience [J], 94: 203-207.
MONSMA F J, JR., MAHAN L C, MCVITTIE L D, et al. 1990. Molecular cloning andexpression of a D1 dopamine receptor linked to adenylyl cyclase activation. Proc Natl AcadSci U S A [J], 87: 6723-6727.
MONTENEGRO M F, BARBOSA F, JR., TANUS-SANTOS J E 2008. Assessment of howpregnancy modifies plasma lead and plasma/whole blood lead ratio in ALAD 1-1 genotypewomen. Basic Clin Pharmacol Toxicol [J], 102: 347-351.
MORIGUCHI S, MARSZALEC W, ZHAO X, et al. 2004. Mechanism of action of galantamineon N-methyl-D-aspartate receptors in rat cortical neurons. J Pharmacol Exp Ther [J], 310:933-942.
MORIGUCHI S, SHIODA N, HAN F, et al. 2009. Galantamine enhancement of long-termpotentiation is mediated by calcium/calmodulin-dependent protein kinase II and proteinkinase C activation. Hippocampus [J], 19: 844-854.
MORIYA H, TAKAGI Y, NAKANISHI T, et al. 1999. Affinity profiles of various muscarinicantagonists for cloned human muscarinic acetylcholine receptor (mAChR) subtypes andmAChRs in rat heart and submandibular gland. Life Sci [J], 64: 2351-2358.
MULDER A B, NORDQUIST R E, ORGUT O, et al. 2003. Learning-related changes in responsepatterns of prefrontal neurons during instrumental conditioning. Behav Brain Res [J], 146:77-88.
MURPHY K P, REID G P, TRENTHAM D R, et al. 1997. Activation of NMDA receptors isnecessary for the induction of associative long-term potentiation in area CA1 of the rathippocampal slice. J Physiol [J], 504 ( Pt 2): 379-385.
MURRAY E A 2007. The amygdala, reward and emotion. Trends Cogn Sci [J], 11: 489-497.
NARAHASHI T, MORIGUCHI S, ZHAO X, et al. 2004. Mechanisms of action of cognitiveenhancers on neuroreceptors. Biol Pharm Bull [J], 27: 1701-1706.
NARITA M, FUNADA M, SUZUKI T 2001. Regulations of opioid dependence by opioid receptortypes. Pharmacol Ther [J], 89: 1-15.
NARITA M, KANEKO C, MIYOSHI K, et al. 2006. Chronic pain induces anxiety withconcomitant changes in opioidergic function in the amygdala. Neuropsychopharmacology [J],31: 739-750.
NATION J R, LIVERMORE C L, BURKEY R T 1996. Chronic lead exposure attenuatessensitization to the locomotor-stimulating effects of cocaine. Drug Alcohol Depend [J], 41:143-149.
NEEDLEMAN H L, GATSONIS C A 1990. Low-level lead exposure and the IQ of children. Ameta-analysis of modern studies. JAMA [J], 263: 673-678.
NEHRU B, KANWAR S S 2007. Modulation by N-acetylcysteine of lead-induced alterations inrat brain: reduced glutathione levels and morphology. Toxicol Mech Methods [J], 17:289-293.
NESTLER E J 2001a. Molecular basis of long-term plasticity underlying addiction. Nat RevNeurosci [J], 2: 119-128.
NESTLER E J 2001b. Neurobiology. Total recall-the memory of addiction. Science [J], 292:2266-2267.
NESTLER E J, AGHAJANIAN G K 1997. Molecular and cellular basis of addiction. Science [J],278: 58-63.NEYLAN T C 2000. Memory and the Medial Temporal Lobe: Patient H. M. J NeuropsychiatryClin Neurosci [J], 12.
NIKFAR S, ABDOLLAHI M, SHARIFZADEH M, et al. 1998. Interaction between lead acetateand morphine on antinociception in mice by formalin test. Gen Pharmacol [J], 30: 489-493.
NISKAR A S, BUCHANAN S, MEYER P A 2005. A federal agency's role in fulfilling the publichealth core functions: the childhood lead poisoning prevention program model. J PublicHealth Manag Pract [J], 11: 50-58.
NOLTE J 1981. The human brainL an introduction to its functional anatomy. [M]. The C.V.Mosbycompany; St.Louis.
NORDBERG A 1999. PET studies and cholinergic therapy in Alzheimer's disease. Rev Neurol(Paris) [J], 155 Suppl 4: S53-63.
NORDBERG A, SVENSSON A L 1998. Cholinesterase inhibitors in the treatment of Alzheimer'sdisease: a comparison of tolerability and pharmacology. Drug Saf [J], 19: 465-480.
NOWAK L, BREGESTOVSKI P, ASCHER P, et al. 1984. Magnesium gates glutamate-activatedchannels in mouse central neurones. Nature [J], 307: 462-465.
OBERTO A, MARKS N, EVANS H L, et al. 1996. Lead (Pb+2) promotes apoptosis in newbornrat cerebellar neurons: pathological implications. J Pharmacol Exp Ther [J], 279: 435-442.
OLDS J 1972. Learning and the hippocampus. Rev Can Biol [J], 31: Suppl:215-238.
OLPE H R, KLEBS K, KUNG E, et al. 1987. Cholinomimetics induce theta rhythm and reducehippocampal pyramidal cell excitability. Eur J Pharmacol [J], 142: 275-283.
ONO T, NISHIJO H, UWANO T 1995. Amygdala role in conditioned associative learning. ProgNeurobiol [J], 46: 401-422.
PAGLIUSI S R, GERRARD P, ABDALLAH M, et al. 1994. Age-related changes in expression ofAMPA-selective glutamate receptor subunits: is calcium-permeability altered in hippocampalneurons? Neuroscience [J], 61: 429-433.
PALUCHA A, BRANSKI P, PILC A 2004. Selective mGlu5 receptor antagonist MTEP attenuatesnaloxone-induced morphine withdrawal symptoms. Pol J Pharmacol [J], 56: 863-866.
PAN Z Z 1998. mu-Opposing actions of the kappa-opioid receptor. Trends Pharmacol Sci [J], 19:94-98.
PAPEZ J W 1995. A proposed mechanism of emotion. 1937. J Neuropsychiatry Clin Neurosci [J],7: 103-112.
PARK S E, KIM N D, YOO Y H 2004. Acetylcholinesterase plays a pivotal role in apoptosomeformation. Cancer Res [J], 64: 2652-2655.
PARNETTI L, SENIN U, MECOCCI P 1997. Cognitive enhancement therapy for Alzheimer'sdisease. The way forward. Drugs [J], 53: 752-768.
PARTL S, HERBST H, SCHAEPER F, et al. 1998. GFAP gene expression is altered in young ratsfollowing developmental low level lead exposure. Neurotoxicology [J], 19: 547-551.
PASTERNAK G W 1995. Nitric oxide and opioid tolerance. NIDA Res Monogr [J], 147: 182-194.
PATERSON D, NORDBERG A 2000. Neuronal nicotinic receptors in the human brain. ProgNeurobiol [J], 61: 75-111.
PENG H, DERRICK B E, MARTINEZ J L, JR. 2003. Identification of upregulated SCG10mRNA expression associated with late-phase long-term potentiation in the rat hippocampalSchaffer-CA1 pathway in vivo. J Neurosci [J], 23: 6617-6626.
PENNARTZ C M, GROENEWEGEN H J, LOPES DA SILVA F H 1994. The nucleus accumbensas a complex of functionally distinct neuronal ensembles: an integration of behavioural,electrophysiological and anatomical data. Prog Neurobiol [J], 42: 719-761.
PERRY D C, XIAO Y, NGUYEN H N, et al. 2002. Measuring nicotinic receptors withcharacteristics of alpha4beta2, alpha3beta2 and alpha3beta4 subtypes in rat tissues byautoradiography. J Neurochem [J], 82: 468-481.
PERRY E K, TOMLINSON B E, BLESSED G, et al. 1978. Correlation of cholinergicabnormalities with senile plaques and mental test scores in senile dementia. Br Med J [J], 2:1457-1459.
PERSSON A I, THORLIN T, BULL C, et al. 2003. Mu- and delta-opioid receptor antagonistsdecrease proliferation and increase neurogenesis in cultures of rat adult hippocampalprogenitors. Eur J Neurosci [J], 17: 1159-1172.
PFRIEGER F W, GOTTMANN K, LUX H D 1994. Kinetics of GABAB receptor-mediatedinhibition of calcium currents and excitatory synaptic transmission in hippocampal neuronsin vitro. Neuron [J], 12: 97-107.
PHELPS D S, LITWACK G 1982. An electrophoretic characterization of the glucocorticoidresponse of the Fu5-5 rat hepatoma cell line. Eur J Biochem [J], 126: 407-415.
PICK M, PERRY C, LAPIDOT T, et al. 2006. Stress-induced cholinergic signaling promotesinflammation-associated thrombopoiesis. Blood [J], 107: 3397-3406.
PIERCE T L, WESSENDORF M W 2000. Immunocytochemical mapping ofendomorphin-2-immunoreactivity in rat brain. J Chem Neuroanat [J], 18: 181-207.
PIRKLE J L, BRODY D J, GUNTER E W, et al. 1994. The decline in blood lead levels in theUnited States. The National Health and Nutrition Examination Surveys (NHANES). JAMA[J], 272: 284-291.
PLATT B, CARPENTER D O, BUSSELBERG D, et al. 1995. Aluminum impairs hippocampallong-term potentiation in rats in vitro and in vivo. Exp Neurol [J], 134: 73-86.
PLUSQUELLEC P, MUCKLE G, DEWAILLY E, et al. 2007. The relation of low-level prenatallead exposure to behavioral indicators of attention in Inuit infants in Arctic Quebec.Neurotoxicol Teratol [J], 29: 527-537.
POCOCK S J, SMITH M, BAGHURST P 1994. Environmental lead and children's intelligence: asystematic review of the epidemiological evidence. BMJ [J], 309: 1189-1197.
POPIK P, LAYER R T, FOSSOM L H, et al. 1995. NMDA antagonist properties of the putativeantiaddictive drug, ibogaine. J Pharmacol Exp Ther [J], 275: 753-760.
POWER J M, SAH P 2002. Nuclear calcium signaling evoked by cholinergic stimulation inhippocampal CA1 pyramidal neurons. J Neurosci [J], 22: 3454-3462.
QUINN M R, HARRIS C L 1995. Lead inhibits Ca(2+)-stimulated nitric oxide synthase activityfrom rat cerebellum. Neurosci Lett [J], 196: 65-68.
RADCLIFFE K A, FISHER J L, GRAY R, et al. 1999. Nicotinic modulation of glutamate andGABA synaptic transmission of hippocampal neurons. Ann N Y Acad Sci [J], 868: 591-610.
RAMALHO R M, RIBEIRO P S, SOLA S, et al. 2004. Inhibition of the E2F-1/p53/Bax pathwayby tauroursodeoxycholic acid in amyloid beta-peptide-induced apoptosis of PC12 cells. JNeurochem [J], 90: 567-575.
RAMESH G T, JADHAV A L 2001. Levels of protein kinase C and nitric oxide synthase activityin rats exposed to sub chronic low level lead. Mol Cell Biochem [J], 223: 27-33.
RAMESH G T, MANNA S K, AGGARWAL B B, et al. 2001. Lead exposure activates nuclearfactor kappa B, activator protein-1, c-Jun N-terminal kinase and caspases in the rat brain.Toxicol Lett [J], 123: 195-207.
REDDY G R, DEVI B C, CHETTY C S 2007. Developmental lead neurotoxicity: alterations inbrain cholinergic system. Neurotoxicology [J], 28: 402-407.
RIEKKINEN P, JR., SIRVIO J, RIEKKINEN P 1990. The effects of THA on medial septallesion-induced memory defects. Pharmacol Biochem Behav [J], 36: 237-241.
ROBINSON T E, BERRIDGE K C 1993. The neural basis of drug craving: anincentive-sensitization theory of addiction. Brain Res Brain Res Rev [J], 18: 247-291.
ROBINSON T E, GORNY G, SAVAGE V R, et al. 2002. Widespread but regionally specificeffects of experimenter- versus self-administered morphine on dendritic spines in the nucleusaccumbens, hippocampus, and neocortex of adult rats. Synapse [J], 46: 271-279.
ROBINSON T E, KOLB B 2004. Structural plasticity associated with exposure to drugs of abuse.Neuropharmacology [J], 47 Suppl 1: 33-46.
RODRIGUES S M, SCHAFE G E, LEDOUX J E 2004. Molecular mechanisms underlyingemotional learning and memory in the lateral amygdala. Neuron [J], 44: 75-91.
ROGERS S L, FRIEDHOFF L T 1998. Pharmacokinetic and pharmacodynamic profile ofdonepezil HCl following single oral doses. Br J Clin Pharmacol [J], 46 Suppl 1: 1-6.
ROSEN J F 1992. Health effects of lead at low exposure levels. Expert consensus and rationale forlowering the definition of childhood lead poisoning. Am J Dis Child [J], 146: 1278-1281.
ROSLER M, ANAND R, CICIN-SAIN A, et al. 1999. Efficacy and safety of rivastigmine inpatients with Alzheimer's disease: international randomised controlled trial. BMJ [J], 318:633-638.
ROTHENBERG S J, KONDRASHOV V, MANALO M, et al. 2001. Seasonal variation in bonelead contribution to blood lead during pregnancy. Environ Res [J], 85: 191-194.
ROUTTENBERG A 1986. Synaptic plasticity and protein kinase C. Prog Brain Res [J], 69:211-234.
RUAN D Y, CHEN J T, ZHAO C, et al. 1998. Impairment of long-term potentiation andpaired-pulse facilitation in rat hippocampal dentate gyrus following developmental leadexposure in vivo. Brain Res [J], 806: 196-201.
SAIMI Y, KUNG C 2002. Calmodulin as an ion channel subunit. Annu Rev Physiol [J], 64:289-311.
SAKAGAMI M, TSUTSUI K 1999. The hierarchical organization of decision making in theprimate prefrontal cortex. Neurosci Res [J], 34: 79-89.
SANIN L H, GONZALEZ-COSSIO T, ROMIEU I, et al. 2001. Effect of maternal lead burden oninfant weight and weight gain at one month of age among breastfed infants. Pediatrics [J],107: 1016-1023.
SANTE A B, NOBRE M J, BRANDAO M L 2000. Place aversion induced by blockade of mu oractivation of kappa opioid receptors in the dorsal periaqueductal gray matter. BehavPharmacol [J], 11: 583-589.
SANTOS M D, ALKONDON M, PEREIRA E F, et al. 2002. The nicotinic allosteric potentiatingligand galantamine facilitates synaptic transmission in the mammalian central nervous system.Mol Pharmacol [J], 61: 1222-1234.
SASTRY B V, SADAVONGVIVAD C 1978. Cholinergic systems in non-nervous tissues.Pharmacol Rev [J], 30: 65-132.
SCHILSTROM B, IVANOV V B, WIKER C, et al. 2007. Galantamine enhances dopaminergicneurotransmission in vivo via allosteric potentiation of nicotinic acetylcholine receptors.Neuropsychopharmacology [J], 32: 43-53.
SCHOEPP D D 1993. The biochemical pharmacology of metabotropic glutamate receptors.Biochem Soc Trans [J], 21: 97-102.
SCHRATTENHOLZ A, PEREIRA E F, ROTH U, et al. 1996. Agonist responses of neuronalnicotinic acetylcholine receptors are potentiated by a novel class of allosterically actingligands. Mol Pharmacol [J], 49: 1-6.
SCHULER V, LUSCHER C, BLANCHET C, et al. 2001. Epilepsy, hyperalgesia, impairedmemory, and loss of pre- and postsynaptic GABA(B) responses in mice lacking GABA(B(1)).Neuron [J], 31: 47-58.
SCOTT L J, GOA K L 2000. Galantamine: a review of its use in Alzheimer's disease. Drugs [J],60: 1095-1122.
SCOVILLE W B, MILNER B 1957. Loss of recent memory after bilateral hippocampal lesions. JNeurol Neurosurg Psychiatry [J], 20: 11-21.
SEGAL M, AUERBACH J M 1997. Muscarinic receptors involved in hippocampal plasticity. LifeSci [J], 60: 1085-1091.
SEGUELA P, WADICHE J, DINELEY-MILLER K, et al. 1993. Molecular cloning, functionalproperties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeableto calcium. J Neurosci [J], 13: 596-604.
SHARP B M, ROY S, BIDLACK J M 1998. Evidence for opioid receptors on cells involved inhost defense and the immune system. J Neuroimmunol [J], 83: 45-56.
SHIMIZU E, TANG Y P, RAMPON C, et al. 2000. NMDA receptor-dependent synapticreinforcement as a crucial process for memory consolidation. Science [J], 290: 1170-1174.
SILBERGELD E K, FALES J T, GOLDBERG A M 1974. The effects of inorganic lead on theneuromuscular junction. Neuropharmacology [J], 13: 795-801.
SILVESTRELLI G, LANARI A, PARNETTI L, et al. 2006. Treatment of Alzheimer's disease:from pharmacology to a better understanding of disease pathophysiology. Mech Ageing Dev[J], 127: 148-157.
SIMMONS M L, CHAVKIN C 1996. Endogenous opioid regulation of hippocampal function. IntRev Neurobiol [J], 39: 145-196.
SIMONS T J 1993. Lead-calcium interactions in cellular lead toxicity. Neurotoxicology [J], 14:77-85.
SKOCZYNSKA A, GRUBER K, BELOWSKA-BIEN K, et al. 2007. [Risk of cadrdiovasculardiseases in lead-exposed workers of crystal glassworks. Part I. Effect of lead on bloodpressure and lipid metabolism]. Med Pr [J], 58: 475-483.
SMART T G 1997. Regulation of excitatory and inhibitory neurotransmitter-gated ion channels byprotein phosphorylation. Curr Opin Neurobiol [J], 7: 358-367.
SOFRONIEW M V, PEARSON R C 1985. Degeneration of cholinergic neurons in the basalnucleus following kainic or N-methyl-D-aspartic acid application to the cerebral cortex in therat. Brain Res [J], 339: 186-190.
SORA I, TAKAHASHI N, FUNADA M, et al. 1997. Opiate receptor knockout mice define mureceptor roles in endogenous nociceptive responses and morphine-induced analgesia. ProcNatl Acad Sci U S A [J], 94: 1544-1549.
SPAGNOLI A, LUCCA U, MENASCE G, et al. 1991. Long-term acetyl-L-carnitine treatment inAlzheimer's disease. Neurology [J], 41: 1726-1732.
SPANAGEL R, ALMEIDA O F, BARTL C, et al. 1994. Endogenous kappa-opioid systems inopiate withdrawal: role in aversion and accompanying changes in mesolimbic dopaminerelease. Psychopharmacology (Berl) [J], 115: 121-127.
STANTON P K, SEJNOWSKI T J 1989. Associative long-term depression in the hippocampusinduced by hebbian covariance. Nature [J], 339: 215-218.
STEELE P M, MAUK M D 1999. Inhibitory control of LTP and LTD: stability of synapse strength.J Neurophysiol [J], 81: 1559-1566.
STEINER D, AVIDOR-REISS T, SCHALLMACH E, et al. 2005. Regulation of adenylate cyclasetype VIII splice variants by acute and chronic Gi/o-coupled receptor activation. Biochem J [J],386: 341-348.
STEPHENSON J, CZEPULKOWSKI B, HIRST W, et al. 1996. Deletion of theacetylcholinesterase locus at 7q22 associated with myelodysplastic syndromes (MDS) andacute myeloid leukaemia (AML). Leuk Res [J], 20: 235-241.
STRINGER J L, GREENFIELD L J, HACKETT J T, et al. 1983. Blockade of long-termpotentiation by phencyclidine and sigma opiates in the hippocampus in vivo and in vitro.Brain Res [J], 280: 127-138.
STRUZYNSKA L, RAFALOWSKA U 1994. The effect of lead on dopamine, GABA andhistidine spontaneous and KCl-dependent releases from rat brain synaptosomes. ActaNeurobiol Exp (Wars) [J], 54: 201-207.
SUAREZ-ROCA H, MAIXNER W 1995. Morphine produces a biphasic modulation of substanceP release from cultured dorsal root ganglion neurons. Neurosci Lett [J], 194: 41-44.
SUI L, RUAN D Y 2000. Impairment of the Ca2+-permeable AMPA/kainate receptors by leadexposure in organotypic rat hippocampal slice cultures. Pharmacol Toxicol [J], 87: 204-210.
SUN X, TIAN X, TOMSIG J L, et al. 1999. Analysis of differential effects of Pb2+ on proteinkinase C isozymes. Toxicol Appl Pharmacol [J], 156: 40-45.
SUSZKIW J B 2004. Presynaptic disruption of transmitter release by lead. Neurotoxicology [J],25: 599-604.
SWEENEY J E, HOHMANN C F, MORAN T H, et al. 1988. A long-acting cholinesteraseinhibitor reverses spatial memory deficits in mice. Pharmacol Biochem Behav [J], 31:141-147.
TAKADA-TAKATORI Y, KUME T, SUGIMOTO M, et al. 2006. Neuroprotective effects ofgalanthamine and tacrine against glutamate neurotoxicity. Eur J Pharmacol [J], 549: 19-26.
TAKUMI Y, RAMIREZ-LEON V, LAAKE P, et al. 1999. Different modes of expression of AMPAand NMDA receptors in hippocampal synapses. Nat Neurosci [J], 2: 618-624.
TANIUCHI M, SCHWEITZER J B, JOHNSON E M, JR. 1986. Nerve growth factor receptormolecules in rat brain. Proc Natl Acad Sci U S A [J], 83: 1950-1954.
TAO R, AUERBACH S B 1995. Involvement of the dorsal raphe but not median raphe nucleus inmorphine-induced increases in serotonin release in the rat forebrain. Neuroscience [J], 68:553-561.
TEYLER T J, DISCENNA P 1984. Long-term potentiation as a candidate mnemonic device. BrainRes [J], 319: 15-28.
THOMPSON A M, GOSNELL B A, WAGNER J J 2002. Enhancement of long-term potentiationin the rat hippocampus following cocaine exposure. Neuropharmacology [J], 42: 1039-1042.
TOHGI H, ABE T, HASHIGUCHI K, et al. 1994. Remarkable reduction in acetylcholineconcentration in the cerebrospinal fluid from patients with Alzheimer type dementia.Neurosci Lett [J], 177: 139-142.
TORRES G, HOROWITZ J M 1999. Drugs of abuse and brain gene expression. Psychosom Med[J], 61: 630-650.
TOSCANO C D, HASHEMZADEH-GARGARI H, MCGLOTHAN J L, et al. 2002.Developmental Pb2+ exposure alters NMDAR subtypes and reduces CREB phosphorylationin the rat brain. Brain Res Dev Brain Res [J], 139: 217-226.
TOSCANO C D, MCGLOTHAN J L, GUILARTE T R 2003. Lead exposure alters cyclic-AMPresponse element binding protein phosphorylation and binding activity in the developing ratbrain. Brain Res Dev Brain Res [J], 145: 219-228.
TOSCANO C D, O'CALLAGHAN J P, GUILARTE T R 2005. Calcium/calmodulin-dependentprotein kinase II activity and expression are altered in the hippocampus of Pb2+-exposed rats.Brain Res [J], 1044: 51-58.
TROMMER B L, LIU Y B, PASTERNAK J F 1996. Long-term depression at the medial perforantpath-granule cell synapse in developing rat dentate gyrus. Brain Res Dev Brain Res [J], 96:97-108.
TSAO D A, YU H S, CHENG J T, et al. 2000. Alterations in beta-adrenergic receptor density andadenylate cyclase activity in the rat brain treated chronically with lead. Toxicology [J], 146:93-99.
TSIEN J Z, CHEN D F, GERBER D, et al. 1996. Subregion- and cell type-restricted geneknockout in mouse brain. Cell [J], 87: 1317-1326.
TZSCHENTKE T M, SCHMIDT W J 1998. Blockade of morphine- and amphetamine-inducedconditioned place preference in the rat by riluzole. Neurosci Lett [J], 242: 114-116.
UJIHARA H, ALBUQUERQUE E X 1992. Developmental change of the inhibition by lead ofNMDA-activated currents in cultured hippocampal neurons. J Pharmacol Exp Ther [J], 263:868-875.
UNGLESS M A, WHISTLER J L, MALENKA R C, et al. 2001. Single cocaine exposure in vivoinduces long-term potentiation in dopamine neurons. Nature [J], 411: 583-587.
VALLES R, CARDON A L, HEARD H M, et al. 2003. Morphine conditioned place preference isattenuated by perinatal lead exposure. Pharmacol Biochem Behav [J], 75: 295-300.
VAN DER KAM E L, DE VRY J, TZSCHENTKE T M 2009. The mGlu5 receptor antagonist2-methyl-6-(phenylethynyl)pyridine (MPEP) supports intravenous self-administration andinduces conditioned place preference in the rat. Eur J Pharmacol [J], 607: 114-120.
VANCE M A 2007. Hippocrates and lead poisoning. Am J Health Syst Pharm [J], 64: 1584.
VERINA T, ROHDE C A, GUILARTE T R 2007. Environmental lead exposure during early lifealters granule cell neurogenesis and morphology in the hippocampus of young adult rats.Neuroscience [J], 145: 1037-1047.
VETTER S W, LECLERC E 2003. Novel aspects of calmodulin target recognition and activation.Eur J Biochem [J], 270: 404-414.
VICKERS C, PATERSON A T 1986. Two types of chronic lead treatment in C57BL/6 mice:interaction with behavioural determinants of pain. Life Sci [J], 39: 47-53.
VICTOR M, ADAMS R D, COLLINS G H 1989. The Wernicke-Korsakoff Syndrome and RelatedNeurologic Disorders Due to Alcoholism and Malnutrition [M]. F.A.Davis Company;Philadelphia.
WADA E, WADA K, BOULTER J, et al. 1989. Distribution of alpha 2, alpha 3, alpha 4, and beta2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridizationhistochemical study in the rat. J Comp Neurol [J], 284: 314-335.
WAGNER J J, ALGER B E 1995. GABAergic and developmental influences on homosynapticLTD and depotentiation in rat hippocampus. J Neurosci [J], 15: 1577-1586.
WAGNER J J, CAUDLE R M, CHAVKIN C 1992. Kappa-opioids decrease excitatorytransmission in the dentate gyrus of the guinea pig hippocampus. J Neurosci [J], 12: 132-141.
WANG D, NODA Y, ZHOU Y, et al. 2007a. Synergistic effect of combined treatment withrisperidone and galantamine on phencyclidine-induced impairment of latent visuospatiallearning and memory: Role of nAChR activation-dependent increase of dopamine D1receptor-mediated neurotransmission. Neuropharmacology [J], 53: 379-389.
WANG D, NODA Y, ZHOU Y, et al. 2007b. Synergistic effect of galantamine with risperidone onimpairment of social interaction in phencyclidine-treated mice as a schizophrenic animalmodel. Neuropharmacology [J], 52: 1179-1187.
WANG X C, BURBACH J P, TENHAAF J, et al. 1986. Characterization and quantitation ofvasopressin metabolites in the rat brain by specific radioimmunoassay and high-pressureliquid chromatography. Sci Sin B [J], 29: 832-843.
WATT A J, VAN ROSSUM M C, MACLEOD K M, et al. 2000. Activity coregulates quantalAMPA and NMDA currents at neocortical synapses. Neuron [J], 26: 659-670.
WEVERS A, JESKE A, LOBRON C, et al. 1994. Cellular distribution of nicotinic acetylcholinereceptor subunit mRNAs in the human cerebral cortex as revealed by non-isotopic in situhybridization. Brain Res Mol Brain Res [J], 25: 122-128.
WICKENS J R, ABRAHAM W C 1991. The involvement of L-type calcium channels inheterosynaptic long-term depression in the hippocampus. Neurosci Lett [J], 130: 128-132.
WILKINS A, MAJED H, LAYFIELD R, et al. 2003. Oligodendrocytes promote neuronal survivaland axonal length by distinct intracellular mechanisms: a novel role foroligodendrocyte-derived glial cell line-derived neurotrophic factor. J Neurosci [J], 23:4967-4974.
WILLIAMS J T, CHRISTIE M J, MANZONI O 2001. Cellular and synaptic adaptationsmediating opioid dependence. Physiol Rev [J], 81: 299-343.
WONG T M, WU S 2003. Roles of kappa opioid receptors in cardioprotection against ischemia:the signaling mechanisms. Sheng Li Xue Bao [J], 55: 115-120.
XIE C W, LEWIS D V 1991. Opioid-mediated facilitation of long-term potentiation at the lateralperforant path-dentate granule cell synapse. J Pharmacol Exp Ther [J], 256: 289-296.
XU A J, CHEN Z, YANAI K, et al. 2002. Effect of3-[1-(phenylmethyl)-4-piperidinyl]-1-(2,3,4,5-tetrahydro-1H-1-benzazepin-8-yl)-1-propanone fumarate, a novel acetylcholinesterase inhibitor, on spatial cognitiveimpairment induced by chronic cerebral hypoperfusion in rats. Neurosci Lett [J], 331: 33-36.
XU J, LIAN L J, WU C, et al. 2008. Lead induces oxidative stress, DNA damage and alteration ofp53, Bax and Bcl-2 expressions in mice. Food Chem Toxicol [J], 46: 1488-1494.
XU J, YAN C H, YANG B, et al. 2009. The role of metabotropic glutamate receptor 5 indevelopmental lead neurotoxicity. Toxicol Lett [J], 191: 223-230.
XU J Y, HILL K P, BIDLACK J M 1998. The nitric oxide/cyclic GMP system at the supraspinalsite is involved in the development of acute morphine antinociceptive tolerance. J PharmacolExp Ther [J], 284: 196-201.
XU S Z, SHAN C J, BULLOCK L, et al. 2006. Pb2+ reduces PKCs and NF-kappaB in vitro. CellBiol Toxicol [J], 22: 189-198.
YAN D, WANG L, MA F L, et al. 2008. Developmental exposure to lead causes inherent changeson voltage-gated sodium channels in rat hippocampal CA1 neurons. Neuroscience [J], 153:436-445.
YANG X, CRISWELL H E, SIMSON P, et al. 1996. Evidence for a selective effect of ethanol onN-methyl-d-aspartate responses: ethanol affects a subtype of the ifenprodil-sensitiveN-methyl-d-aspartate receptors. J Pharmacol Exp Ther [J], 278: 114-124.
YAO W D, GAINETDINOV R R, ARBUCKLE M I, et al. 2004. Identification of PSD-95 as aregulator of dopamine-mediated synaptic and behavioral plasticity. Neuron [J], 41: 625-638.
YIN W, ZHANG P, HUANG J H, et al. 2009. Stimulation of kappa-opioid receptor reducesisoprenaline-induced cardiac hypertrophy and fibrosis. Eur J Pharmacol [J], 607: 135-142.
YU Z, CHENG G, HU B 1997. Mechanism of colchicine impairment on learning and memory,and protective effect of CGP36742 in mice. Brain Res [J], 750: 53-58.
ZAGON I S, MCLAUGHLIN P J 1977a. Effect of chronic maternal methadone exposure onperinatal development. Biol Neonate [J], 31: 271-282.
ZAGON I S, MCLAUGHLIN P J 1977b. Morphine and brain growth retardation in the rat.Pharmacology [J], 15: 276-282.
ZALUTSKY R A, NICOLL R A 1990. Comparison of two forms of long-term potentiation insingle hippocampal neurons. Science [J], 248: 1619-1624.
ZAREI M M, RADCLIFFE K A, CHEN D, et al. 1999. Distributions of nicotinic acetylcholinereceptor alpha7 and beta2 subunits on cultured hippocampal neurons. Neuroscience [J], 88:755-764.
ZARRINDAST M R, BABAPOOR-FARROKHRAN S, REZAYOF A 2008. Involvement ofopioidergic system of the ventral hippocampus, the nucleus accumbens or the centralamygdala in anxiety-related behavior. Life Sci [J], 82: 1175-1181.
ZHANG D X, LEVY W B 1993. Bicuculline permits the induction of long-term depression byheterosynaptic, translaminar conditioning in the hippocampal dentate gyrus. Brain Res [J],613: 309-312.
ZHANG H S, ZHAO X L, SONG L H, et al. 1998. Inhibition of the specific 3H-DL-Glu bindingin the hippocampus of rat brain by lead. Biomed Environ Sci [J], 11: 81-86.
ZHANG H X, ZHANG W, JIN H W, et al. 2004. Galantamine blocks cloned Kv2.1, but not Kv1.5potassium channels. Brain Res Mol Brain Res [J], 131: 136-140.
ZHANG X J, YANG L, ZHAO Q, et al. 2002a. Induction of acetylcholinesterase expressionduring apoptosis in various cell types. Cell Death Differ [J], 9: 790-800.
ZHANG X Y, LIU A P, RUAN D Y, et al. 2002b. Effect of developmental lead exposure on theexpression of specific NMDA receptor subunit mRNAs in the hippocampus of neonatal ratsby digoxigenin-labeled in situ hybridization histochemistry. Neurotoxicol Teratol [J], 24:149-160.
ZHANG Y L, ZHANG P B, QIU S D, et al. 2006. Effects of ketamine-midazolam anesthesia onthe expression of NMDA and AMPA receptor subunit in the peri-infarction of rat brain. ChinMed J (Engl) [J], 119: 1555-1562.
ZHAO W F, RUAN D Y, XU Y Z, et al. 1999. The effects of chronic lead exposure on long-termdepression in area CA1 and dentate gyrus of rat hippocampus in vitro. Brain Res [J], 818:153-159.
ZHONG W, DONG Z, TIAN M, et al. 2006. Opiate withdrawal induces dynamic expressions ofAMPA receptors and its regulatory molecule CaMKIIalpha in hippocampal synapses. LifeSci [J], 79: 861-869.
ZHOU L F, ZHU Y P 2006. Changes of CREB in rat hippocampus, prefrontal cortex and nucleusaccumbens during three phases of morphine induced conditioned place preference in rats. JZhejiang Univ Sci B [J], 7: 107-113.
曹续政,张黎明,沈月娥2006. NMDA受体介导了加兰他敏对阿尔茨海默病大鼠认知功能的改善.中风与神经疾病杂志[J], 23: 678-680.
曽燕,梁勋厂,施静, et al. 2004.急慢性吗啡应用对外侧穿通纤维-海马CA3直接通路LTP的不同影响.中国药学杂志[J], 39: 822-825.
常艳,薛毅珑2004.阿尔茨海默病的发病机制及其研究进展中国临床康复[J], 8: 693.
邸秀珍,毕国华,孟海燕2007.吗啡依赖大鼠海马长时程增强改变及归元片的干预效应.中国药物依赖性杂志[J], 16: 266-270.
董丽萍,韩明,袁芳2007. I组mGluRs反义寡核苷酸抗谷氨酸对小鼠大脑皮层神经元的兴奋毒性作用.中国应用生理学杂志[J], 23: 438-440.
韩太真,吴馥梅1998.学习与记忆的神经生物学. [M].北京医科大学、中国协和大学联合出版社;北京.
胡前胜,任铁玲,傅洪军2004.低剂量铅对海马神经元神经细胞粘附因子表达的影响.中华预防医学杂志[J], 38: 379-382.
黄芬,李积胜,杨烽2004.慢性染铅大鼠皮层NOS和nNOS神经元的变化.武警医学[J],15: 573-575.
纪庆娥1994.选择性胆碱酯酶抑制剂-加兰他敏.国外医学合成药、生化药、制剂分册[J],15: 93.
江明性,杨藻宸1995.药理学（第四版）[M].人民卫生出版社;北京.
孔庆胜,王文军,李晶2009.儿童生长激素分泌水平及铁、锌、铅对其分泌量的影响.中华预防医学杂志[J], 43: 346.
雷荣辉,张进,易建华2003.铅接触仔鼠学习记忆行为与海马bcl-2和bax基因表达.工业卫生与职业病[J], 29: 226-229.
李峰,刘洋,焦莹2008.吗啡条件性位置偏爱大鼠脑伏核中CaMKⅡ及NOS阳性神经元变化.中国药物依赖性杂志[J]: 341-343.
李国君.,吴德生.,程薇波. 2000.铅对大鼠中枢神经系统中NOS的影响.现代预防医学[J],27: 449-452.
刘巧凤,金清华,申贤淑, et al. 2006.氨基酸对脑海马突触效应和学习记忆的影响.中国临床康复[J], 10: 2.
刘素媛,孙黎光,刑伟1999.慢性铅中毒对大鼠海马区神经细胞Ca2+浓度及Ca2+-ATP酶活性的影响.卫生毒理学杂志[J], 13: 16-21.
马广恩1998.加兰他敏治疗老年痴呆症的研究概况.药学进展[J], 22: 135.
梅镇彤1996.学习记忆的神经机制.生理科学进展[J], 27: 183-188.
阮迪云2001.铅对海马神经元通道、受体和递质的影响及其作用机制.广东微量元素科学[J], 8: 700-710.
唐竹吾,庞懿,张书琴1986.中枢神经系统解剖学[M].上海科学技术出版社;上海.
王晓燕,黄敏仁,韩正敏2004.石蒜属植物中加兰他敏的分离提取及其应用.南京林业大学学报：自然科学版[J], 28: 79-83.
王韵.,韩济生. 1999.一氧化氮在医学中的现在和将来.生理科学进展[J], 30: 94-95.
韦世秀,蒙子卿,叶峻2005.不同阶段海洛因成瘾大鼠脑内单胺递质的变化.中国医院药学杂志[J], 25: 396-398.
徐健,颜崇淮,沈晓明2004.海马代谢型谷氨酸受体与学习记忆的关系研究进展.中国儿童保健杂志[J], 12: 154-156.
徐健,袁崇淮,余晓刚2005.在体铅暴露对发育脑海马mGluR基因表达的影响.中华医学杂志[J], 85: 705-707.
叶翠飞,张兰,张丽2005.牛磺酸对东莨菪碱所致记忆性获得性障碍模型小鼠的改善作用.中国药理学通报[J], 21: 3.
叶智文,娄艾琳,郑华1988.老年大鼠的海马神经元对微量注射Ach的敏感性.生理科学进展[J], 8.
臧梦维,孟爱民,沈琦2000. NO-cGMP信号传导系统的上调参与阿片类药物耐受和戒断的生化机制.药学学报[J], 35: 566-570.
张亨山,赵西龙,宋丽华1997.铅对大鼠海马脑片谷氨酸递质体外释放的影响.中华预防医学杂志[J], 31: 285-287.
张建辉,庞广昌2006.阿片肽的研究进展与展望.食品科学[J], 27: 823-829.
张瑞岭,郝伟2004.慢性吗啡处理大鼠伏隔核、海马CA1区神经元突触界面结构改变.中华精神科杂志[J], 37: 187.
郑希耕,李勇辉,隋南2006.成瘾药物心理依赖及复发的脑机制研究.心理科学进展[J],14: 522-531.
周丽华,姚志彬,陈以慈1998.基底前脑解剖学及临床意义.神经解剖学杂志[J], 14:401-405.
ABE K, NAKATA A, MIZUTANI A, et al. 1994. Facilitatory but nonessential role of themuscarinic cholinergic system in the generation of long-term potentiation of populationspikes in the dentate gyrus in vivo. Neuropharmacology [J], 33: 847-852.
ABRAHAM W C, WICKENS J R 1991. Heterosynaptic long-term depression is facilitated byblockade of inhibition in area CA1 of the hippocampus. Brain Res [J], 546: 336-340.
ADAMS S V, WINTERER J, MULLER W 2004. Muscarinic signaling is required forspike-pairing induction of long-term potentiation at rat Schaffer collateral-CA1 synapses.Hippocampus [J], 14: 413-416.
ALBRIGHT T D, KANDEL E R, POSNER M I 2000. Cognitive neuroscience. Curr OpinNeurobiol [J], 10: 612-624.
ALES E, GULLO F, ARIAS E, et al. 2006. Blockade of Ca2+ -activated K+ channels bygalantamine can also contribute to the potentiation of catecholamine secretion fromchromaffin cells. Eur J Pharmacol [J], 548: 45-52.
ALGER B E, PITLER T A 1995. Retrograde signaling at GABAA-receptor synapses in themammalian CNS. Trends Neurosci [J], 18: 333-340.
ALGER B E, TEYLER T J 1976. Long-term and short-term plasticity in the CA1, CA3, anddentate regions of the rat hippocampal slice. Brain Res [J], 110: 463-480.
ALHEID G F, HEIMER L 1988. New perspectives in basal forebrain organization of specialrelevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, and corticopetalcomponents of substantia innominata. Neuroscience [J], 27: 1-39.
ALKONDON M, ALBUQUERQUE E X 2004. The nicotinic acetylcholine receptor subtypes andtheir function in the hippocampus and cerebral cortex. Prog Brain Res [J], 145: 109-120.
ALKONDON M, COSTA A C, RADHAKRISHNAN V, et al. 1990. Selective blockade ofNMDA-activated channel currents may be implicated in learning deficits caused by lead.FEBS Lett [J], 261: 124-130.
ALTMANN L, SVEINSSON K, WIEGAND H 1991. Long-term potentiation in rat hippocampalslices is impaired following acute lead perfusion. Neurosci Lett [J], 128: 109-112.
ALTMANN L, WEINSBERG F, SVEINSSON K, et al. 1993. Impairment of long-termpotentiation and learning following chronic lead exposure. Toxicol Lett [J], 66: 105-112.
AMUNDSEN T, NAESS I A, HAMMERSTROM J, et al. 2002. [Lead poisoning--an overview].Tidsskr Nor Laegeforen [J], 122: 1473-1476.
ANDERSEN P, SUNDBERG S H, SVEEN O, et al. 1977. Specific long-lasting potentiation ofsynaptic transmission in hippocampal slices. Nature [J], 266: 736-737.
ANDY O J, MITCHELL J 1960. The role of limbic structures in learned behavior. Surg Forum [J],11: 383-385.
ARIAS E, ALES E, GABILAN N H, et al. 2004. Galantamine prevents apoptosis induced bybeta-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors.Neuropharmacology [J], 46: 103-114.
ARON A R, SHOHAMY D, CLARK J, et al. 2004. Human midbrain sensitivity to cognitivefeedback and uncertainty during classification learning. J Neurophysiol [J], 92: 1144-1152.
ATCHISON W D, NARAHASHI T 1984. Mechanism of action of lead on neuromuscularjunctions. Neurotoxicology [J], 5: 267-282.
AUCLAIR A, DROUIN C, COTECCHIA S, et al. 2004. 5-HT2A and alpha1b-adrenergicreceptors entirely mediate dopamine release, locomotor response and behaviouralsensitization to opiates and psychostimulants. Eur J Neurosci [J], 20: 3073-3084.
AUDESIRK G 1987. Effects of in vitro and in vivo lead exposure on voltage-dependent calciumchannels in central neurons of Lymnaea stagnalis. Neurotoxicology [J], 8: 579-592.
AUDESIRK G, AUDESIRK T 1989. Effects of in vitro lead exposure on voltage-sensitive calciumchannels differ among cell types in central neurons of Lymnaea stagnalis. Neurotoxicology[J], 10: 659-669.
BAILEY C C, KITCHEN I 1986. Ontogeny of catecholamine and GABA levels in rat brain: lackof effect of perinatal lead exposure. Toxicol Lett [J], 30: 97-102.
BALSCHUN D, WOLFER D P, GASS P, et al. 2003. Does cAMP response element-bindingprotein have a pivotal role in hippocampal synaptic plasticity and hippocampus-dependentmemory? J Neurosci [J], 23: 6304-6314.
BAO J X, KANDEL E R, HAWKINS R D 1997. Involvement of pre- and postsynapticmechanisms in posttetanic potentiation at Aplysia synapses. Science [J], 275: 969-973.
BAO X, SHU S 1991. The stereotaxic atlas of the rat brain [M]. PEOPLES MEDICALPUBLISHING HOUSE; Beijing.
BARALDI M, ZANOLI P, ROSSI T, et al. 1985. Neurobehavioral and neurochemicalabnormalities of pre- and postnatally lead-exposed rats: zinc, copper and calcium status.Neurobehav Toxicol Teratol [J], 7: 499-509.
BARNES C A 1979. Memory deficits associated with senescence: a neurophysiological andbehavioral study in the rat. J Comp Physiol Psychol [J], 93: 74-104.
BARNES C A, MELTZER J, HOUSTON F, et al. 2000. Chronic treatment of old rats withdonepezil or galantamine: effects on memory, hippocampal plasticity and nicotinic receptors.Neuroscience [J], 99: 17-23.
BARR M L 1979. The human Nervous system：An Anatomic viewpoint. [M]. Harper&RowPublishers Inc.; Hagerstown.
BARRANTES G E, WESTWICK J, WONNACOTT S 1994. Nicotinic acetylcholine receptors inprimary cultures of hippocampal neurons: pharmacology and Ca++ permeability. BiochemSoc Trans [J], 22: 294S.
BASHA M R, WEI W, BAKHEET S A, et al. 2005. The fetal basis of amyloidogenesis: exposureto lead and latent overexpression of amyloid precursor protein and beta-amyloid in the agingbrain. J Neurosci [J], 25: 823-829.
BASHA M R, WEI W, BRYDIE M, et al. 2003. Lead-induced developmental perturbations inhippocampal Sp1 DNA-binding are prevented by zinc supplementation: in vivo evidence forPb and Zn competition. Int J Dev Neurosci [J], 21: 1-12.
BASKIN D S, BROWNING J L, PIROZZOLO F J, et al. 1999. Brain choline acetyltransferaseand mental function in Alzheimer disease. Arch Neurol [J], 56: 1121-1123.
BAXTER M G, BUCCI D J, GORMAN L K, et al. 1995. Selective immunotoxic lesions of basalforebrain cholinergic cells: effects on learning and memory in rats. Behav Neurosci [J], 109:714-722.
BEHL M, ZHANG Y, ZHENG W 2009. Involvement of insulin-degrading enzyme in theclearance of beta-amyloid at the blood-CSF barrier: Consequences of lead exposure.Cerebrospinal Fluid Res [J], 6: 11.
BEILHARZ E J, WILLIAMS C E, DRAGUNOW M, et al. 1995. Mechanisms of delayed celldeath following hypoxic-ischemic injury in the immature rat: evidence for apoptosis duringselective neuronal loss. Brain Res Mol Brain Res [J], 29: 1-14.
BELLUARDO N, MUDO G, BLUM M, et al. 2000. Central nicotinic receptors, neurotrophicfactors and neuroprotection. Behav Brain Res [J], 113: 21-34.
BEN-ARI Y, TREMBLAY E, OTTERSEN O P, et al. 1980. The role of epileptic activity inhippocampal and "remote" cerebral lesions induced by kainic acid. Brain Res [J], 191: 79-97.
BENARDO L S, PRINCE D A 1982. Cholinergic excitation of mammalian hippocampalpyramidal cells. Brain Res [J], 249: 315-331.
BENINGER R J, MILLER R 1998. Dopamine D1-like receptors and reward-related incentivelearning. Neurosci Biobehav Rev [J], 22: 335-345.
BENKE T A, LUTHI A, ISAAC J T, et al. 1998. Modulation of AMPA receptor unitaryconductance by synaptic activity. Nature [J], 393: 793-797.
BERG D K, CONROY W G 2002. Nicotinic alpha 7 receptors: synaptic options and downstreamsignaling in neurons. J Neurobiol [J], 53: 512-523.
BERGLUND M, AKESSON A, BJELLERUP P, et al. 2000. Metal-bone interactions. Toxicol Lett[J], 112-113: 219-225.
BERHOW M T, RUSSELL D S, TERWILLIGER R Z, et al. 1995. Influence of neurotrophicfactors on morphine- and cocaine-induced biochemical changes in the mesolimbic dopaminesystem. Neuroscience [J], 68: 969-979.
BIDLACK J M 2000. Detection and function of opioid receptors on cells from the immune system.Clin Diagn Lab Immunol [J], 7: 719-723.
BIGBEE J W, SHARMA K V, GUPTA J J, et al. 1999. Morphogenic role for acetylcholinesterasein axonal outgrowth during neural development. Environ Health Perspect [J], 107 Suppl 1:81-87.
BLAIR H T, SCHAFE G E, BAUER E P, et al. 2001. Synaptic plasticity in the lateral amygdala: acellular hypothesis of fear conditioning. Learn Mem [J], 8: 229-242.
BLISS T V, COLLINGRIDGE G L 1993. A synaptic model of memory: long-term potentiation inthe hippocampus. Nature [J], 361: 31-39.
BLISS T V, LOMO T 1973. Long-lasting potentiation of synaptic transmission in the dentate areaof the anaesthetized rabbit following stimulation of the perforant path. J Physiol [J], 232:331-356.
BOADA-ROVIRA M, BRODATY H, CRAS P, et al. 2004. Efficacy and safety of donepezil inpatients with Alzheimer's disease: results of a global, multinational, clinical experience study.Drugs Aging [J], 21: 43-53.
BOHUS B, URBAN I, VAN WIMERSMA GREIDANUS T B, et al. 1978. Opposite effects ofoxytocin and vasopressin on avoidance behaviour and hippocampal theta rhythm in the rat.Neuropharmacology [J], 17: 239-247.
BOISSIERE F, FAUCHEUX B, AGID Y, et al. 1997. Choline acetyltransferase mRNA expressionin the striatal neurons of patients with Alzheimer's disease. Neurosci Lett [J], 225: 169-172.
BOLIN C M, BASHA R, COX D, et al. 2006. Exposure to lead and the developmental origin ofoxidative DNA damage in the aging brain. FASEB J [J], 20: 788-790.
BONDY S C, HONG J S, TILSON H A, et al. 1985. Effects of triethyl lead on hot-plateresponsiveness and biochemical properties of hippocampus. Pharmacol Biochem Behav [J],22: 1007-1011.
BOUTON C M, FRELIN L P, FORDE C E, et al. 2001. Synaptotagmin I is a molecular target forlead. J Neurochem [J], 76: 1724-1735.
BRAGA M F, PEREIRA E F, MIKE A, et al. 2004. Pb2+ via protein kinase C inhibits nicotiniccholinergic modulation of synaptic transmission in the hippocampus. J Pharmacol Exp Ther[J], 311: 700-710.
BRAMHAM C R 1992. Opioid receptor dependent long-term potentiation: peptidergic regulationof synaptic plasticity in the hippocampus. Neurochem Int [J], 20: 441-455.
BRAMHAM C R, ERRINGTON M L, BLISS T V 1988. Naloxone blocks the induction oflong-term potentiation in the lateral but not in the medial perforant pathway in theanesthetized rat. Brain Res [J], 449: 352-356.
BRAMHAM C R, MILGRAM N W, SREBRO B 1991. Delta opioid receptor activation isrequired to induce LTP of synaptic transmission in the lateral perforant path in vivo. BrainRes [J], 567: 42-50.
BRAMHAM C R, SARVEY J M 1996. Endogenous activation of mu and delta-1 opioid receptorsis required for long-term potentiation induction in the lateral perforant path: dependence onGABAergic inhibition. J Neurosci [J], 16: 8123-8131.
BREDT D S, SNYDER S H 1992. Nitric oxide, a novel neuronal messenger. Neuron [J], 8: 3-11.
BUCHEL C, MORRIS J, DOLAN R J, et al. 1998. Brain systems mediating aversive conditioning:an event-related fMRI study. Neuron [J], 20: 947-957.
BUSSELBERG D, EVANS M L, RAHMANN H, et al. 1991. Lead and zinc block avoltage-activated calcium channel of Aplysia neurons. J Neurophysiol [J], 65: 786-795.
BUSSELBERG D, MICHAEL D, PLATT B 1994. Pb2+ reduces voltage- andN-methyl-D-aspartate (NMDA)-activated calcium channel currents. Cell Mol Neurobiol [J],14: 711-722.
CAJAL S 1911. Histologie du Systeme Nerveux de l'Homme et des Vertebretes [M]; Paris.
CALABRESI P, CENTONZE D, GUBELLINI P, et al. 1999. Glutamate-triggered events inducingcorticostriatal long-term depression. J Neurosci [J], 19: 6102-6110.
CALABRESI P, NAPOLITANO M, CENTONZE D, et al. 2000. Tissue plasminogen activatorcontrols multiple forms of synaptic plasticity and memory. Eur J Neurosci [J], 12: 1002-1012.
CANFIELD R L, HENDERSON C R, JR., CORY-SLECHTA D A, et al. 2003. Intellectualimpairment in children with blood lead concentrations below 10 microg per deciliter. N EnglJ Med [J], 348: 1517-1526.
CAPONE F, ADRIANI W, SHUMILINA M, et al. 2008. Autoantibodies against opioid orglutamate receptors are associated with changes in morphine reward and physicaldependence in mice. Psychopharmacology (Berl) [J], 197: 535-548.
CARICATI-NETO A, D'ANGELO L C, REUTER H, et al. 2004. Enhancement of purinergicneurotransmission by galantamine and other acetylcholinesterase inhibitors in the rat vasdeferens. Eur J Pharmacol [J], 503: 191-201.
CHAPMAN C R, TUCKETT R P, SONG C W 2008. Pain and stress in a systems perspective:reciprocal neural, endocrine, and immune interactions. J Pain [J], 9: 122-145.
CHEN L, HUANG L Y 1992. Protein kinase C reduces Mg2+ block of NMDA-receptor channelsas a mechanism of modulation. Nature [J], 356: 521-523.
CHEN Z, ITO K, FUJII S, et al. 1996. Roles of dopamine receptors in long-term depression:enhancement via D1 receptors and inhibition via D2 receptors. Receptors Channels [J], 4:1-8.
CHIAMULERA C, EPPING-JORDAN M P, ZOCCHI A, et al. 2001. Reinforcing and locomotorstimulant effects of cocaine are absent in mGluR5 null mutant mice. Nat Neurosci [J], 4:873-874.
CHOTINER J K, KHORASANI H, NAIRN A C, et al. 2003. Adenylyl cyclase-dependent form ofchemical long-term potentiation triggers translational regulation at the elongation step.Neuroscience [J], 116: 743-752.
CHRISTOFI G, NOWICKY A V, BOLSOVER S R, et al. 1993. The postsynaptic induction ofnonassociative long-term depression of excitatory synaptic transmission in rat hippocampalslices. J Neurophysiol [J], 69: 219-229.
COHN J, CORY-SLECHTA D A 1994. Assessment of the role of dopaminergic systems inlead-induced learning impairments using a repeated acquisition and performance baseline.Neurotoxicology [J], 15: 913-926.
COLEMAN B A, TAYLOR P 1996. Regulation of acetylcholinesterase expression duringneuronal differentiation. J Biol Chem [J], 271: 4410-4416.
COLINO A, HUANG Y Y, MALENKA R C 1992. Characterization of the integration time for thestabilization of long-term potentiation in area CA1 of the hippocampus. J Neurosci [J], 12:180-187.
COLLINGRIDGE G L, BLISS T V 1995. Memories of NMDA receptors and LTP. TrendsNeurosci [J], 18: 54-56.
COLLINGRIDGE G L, KEHL S J, MCLENNAN H 1983. Excitatory amino acids in synaptictransmission in the Schaffer collateral-commissural pathway of the rat hippocampus. JPhysiol [J], 334: 33-46.
COLLINGRIDGE G L, RANDALL A D, DAVIES C H, et al. 1992. The synaptic activation ofNMDA receptors and Ca2+ signalling in neurons. Ciba Found Symp [J], 164: 162-171;discussion 172-165.
CORDOVA F M, RODRIGUES A L, GIACOMELLI M B, et al. 2004. Lead stimulates ERK1/2and p38MAPK phosphorylation in the hippocampus of immature rats. Brain Res [J], 998:65-72.
CORY-SLECHTA D A 1995. Relationships between lead-induced learning impairments andchanges in dopaminergic, cholinergic, and glutamatergic neurotransmitter system functions.Annu Rev Pharmacol Toxicol [J], 35: 391-415.
CREMIN J D, JR., SMITH D R 2002. In vitro vs in vivo Pb effects on brain protein kinase Cactivity. Environ Res [J], 90: 191-199.
CUMMINGS J L 2004. Alzheimer's disease. N Engl J Med [J], 351: 56-67.
DAJAS-BAILADOR F A, HEIMALA K, WONNACOTT S 2003. The allosteric potentiation ofnicotinic acetylcholine receptors by galantamine is transduced into cellular responses inneurons: Ca2+ signals and neurotransmitter release. Mol Pharmacol [J], 64: 1217-1226.
DAMASIO A R 1989. Time-locked multiregional retroactivation: a systems-level proposal for theneural substrates of recall and recognition. Cognition [J], 33: 25-62.
DAMASIO A R, TRANEL D, DAMASIO H 1989. Handbook of Neuropsychology [M]. Elsevier;Amsterdam.
DAVIES P, TERRY R D 1981. Cortical somatostatin-like immunoreactivity in cases ofAlzheimer's disease and senile dementia of the Alzheimer type. Neurobiol Aging [J], 2: 9-14.
DAVIS J M, ELIAS R W, GRANT L D 1993. Current issues in human lead exposure andregulation of lead. Neurotoxicology [J], 14: 15-27.
DE ROVER M, LODDER J C, SCHOFFELMEER A N, et al. 2005. Intermittent morphinetreatment induces a long-lasting increase in cholinergic modulation of GABAergic synapsesin nucleus accumbens of adult rats. Synapse [J], 55: 17-25.
DENG W, PORETZ R D 2002. Protein kinase C activation is required for the lead-inducedinhibition of proliferation and differentiation of cultured oligodendroglial progenitor cells.Brain Res [J], 929: 87-95.
DESMOND N L, COLBERT C M, ZHANG D X, et al. 1991. NMDA receptor antagonists blockthe induction of long-term depression in the hippocampal dentate gyrus of the anesthetizedrat. Brain Res [J], 552: 93-98.
DESMOND N L, LEVY W B 1983. Synaptic correlates of associative potentiation/depression: anultrastructural study in the hippocampus. Brain Res [J], 265: 21-30.
DHAWAN B N, CESSELIN F, RAGHUBIR R, et al. 1996. International Union of Pharmacology.XII. Classification of opioid receptors. Pharmacol Rev [J], 48: 567-592.
DIETRICH K N, WARE J H, SALGANIK M, et al. 2004. Effect of chelation therapy on theneuropsychological and behavioral development of lead-exposed children after school entry.Pediatrics [J], 114: 19-26.
DO V H, MARTINEZ C O, MARTINEZ J L, JR., et al. 2002. Long-term potentiation in directperforant path projections to the hippocampal CA3 region in vivo. J Neurophysiol [J], 87:669-678.
DONG H, XIANG Y Y, FARCHI N, et al. 2004. Excessive expression of acetylcholinesteraseimpairs glutamatergic synaptogenesis in hippocampal neurons. J Neurosci [J], 24:8950-8960.
DONG J, YIN H, LIU W, et al. 2005. Congenital iodine deficiency and hypothyroidism impairLTP and decrease C-fos and C-jun expression in rat hippocampus. Neurotoxicology [J], 26:417-426.
DORI A, IFERGANE G, SAAR-LEVY T, et al. 2007. Readthrough acetylcholinesterase ininflammation-associated neuropathies. Life Sci [J], 80: 2369-2374.
DRAGUNOW M, ABRAHAM W C, GOULDING M, et al. 1989. Long-term potentiation and theinduction of c-fos mRNA and proteins in the dentate gyrus of unanesthetized rats. NeurosciLett [J], 101: 274-280.
DRAKE C T, CHAVKIN C, MILNER T A 2007. Opioid systems in the dentate gyrus. Prog BrainRes [J], 163: 245-263.
DRAKE C T, MILNER T A 1999. Mu opioid receptors are in somatodendritic and axonalcompartments of GABAergic neurons in rat hippocampal formation. Brain Res [J], 849:203-215.
DUDAI Y 1989. The neurobiology and memory:Concepts,findings,trends. [M]. Oxford UniversityPress; Oxford.
DUDEK S M, BEAR M F 1993. Bidirectional long-term modification of synaptic effectiveness inthe adult and immature hippocampus. J Neurosci [J], 13: 2910-2918.
DUNBAR G L, RYLETT R J, SCHMIDT B M, et al. 1993. Hippocampal cholineacetyltransferase activity correlates with spatial learning in aged rats. Brain Res [J], 604:266-272.
DUNWIDDIE T, LYNCH G 1978. Long-term potentiation and depression of synaptic responses inthe rat hippocampus: localization and frequency dependency. J Physiol [J], 276: 353-367.
EAGGER S A, LEVY R, SAHAKIAN B J 1991. Tacrine in Alzheimer's disease. Lancet [J], 337:989-992.
ECCLES J C, KRNJEVIC K 1959. Presynaptic changes associated with post-tetanic potentiationin the spinal cord. J Physiol [J], 149: 274-287.
ECCLES J C, RALL W 1950. Post-tetanic potentiation of responses of motoneurones. Nature [J],166: 465-466.
ELLIS M R, KANE K Y 2000. Lightening the lead load in children. Am Fam Physician [J], 62:545-554, 559-560.
ENSMINGER M E, ANTHONY J C, MCCORD J 1997. The inner city and drug use: initialfindings from an epidemiological study. Drug Alcohol Depend [J], 48: 175-184.
ERNFORS P, BRAMHAM C R 2003. The coupling of a trkB tyrosine residue to LTP. TrendsNeurosci [J], 26: 171-173.
EZOULIN M J, OMBETTA J E, DUTERTRE-CATELLA H, et al. 2008. Antioxidative propertiesof galantamine on neuronal damage induced by hydrogen peroxide in SK-N-SH cells.Neurotoxicology [J], 29: 270-277.
FABIAN-FINE R, SKEHEL P, ERRINGTON M L, et al. 2001. Ultrastructural distribution of thealpha7 nicotinic acetylcholine receptor subunit in rat hippocampus. J Neurosci [J], 21:7993-8003.
FEDER R, RANCK J B, JR. 1973. Studies on single neurons in dorsal hippocampal formation andseptum in unrestrained rats. II. Hippocampal slow waves and theta cell firing during barpressing and other behaviors. Exp Neurol [J], 41: 532-555.
FICHNA J, JANECKA A, PIESTRZENIEWICZ M, et al. 2007. Antidepressant-like effect ofendomorphin-1 and endomorphin-2 in mice. Neuropsychopharmacology [J], 32: 813-821.
FLORA S J, TANDON S K 1986. Preventive and therapeutic effects of thiamine, ascorbic acidand their combination in lead intoxication. Acta Pharmacol Toxicol (Copenh) [J], 58:374-378.
FORD D H, RHINES R K 1979. Prenatal exposure to methadone HCL in relationship to body andbrain growth in the rat. Acta Neurol Scand [J], 59: 248-262.
FUJII S, JI Z, MORITA N, et al. 1999. Acute and chronic nicotine exposure differentially facilitatethe induction of LTP. Brain Res [J], 846: 137-143.
FUKUNAGA K, MULLER D, MIYAMOTO E 1995. Increased phosphorylation ofCa2+/calmodulin-dependent protein kinase II and its endogenous substrates in the inductionof long-term potentiation. J Biol Chem [J], 270: 6119-6124.
FULLMER C S, EDELSTEIN S, WASSERMAN R H 1985. Lead-binding properties of intestinalcalcium-binding proteins. J Biol Chem [J], 260: 6816-6819.
GARZA A, VEGA R, SOTO E 2006. Cellular mechanisms of lead neurotoxicity. Med Sci Monit[J], 12: RA57-65.
GE S, DANI J A 2005. Nicotinic acetylcholine receptors at glutamate synapses facilitate long-termdepression or potentiation. J Neurosci [J], 25: 6084-6091.
GEDEON Y, RAMESH G T, WELLMAN P J, et al. 2001. Changes in mesocorticolimbicdopamine and D1/D2 receptor levels after low level lead exposure: a time course study.Toxicol Lett [J], 123: 217-226.
GETOVA D P, BOWERY N G 2001. Effects of high-affinity GABAB receptor antagonists onactive and passive avoidance responding in rodents withgamma-hydroxybutyrolactone-induced absence syndrome. Psychopharmacology (Berl) [J],157: 89-95.
GHELARDINI C, GALEOTTI N, MATUCCI R, et al. 1999. Antisense 'knockdowns' of M1receptors induces transient anterograde amnesia in mice. Neuropharmacology [J], 38:339-348.
GIACOBINI E 1998. Cholinergic foundations of Alzheimer's disease therapy. J Physiol Paris [J],92: 283-287.
GILBERT M E, LASLEY S M 2002. Long-term consequences of developmental exposure to leador polychlorinated biphenyls: Synaptic transmission and plasticity in the rodent CNS.Environ Toxicol Pharmacol [J], 12: 105-117.
GILBERT M E, MACK C M, LASLEY S M 1996. Chronic developmental lead exposureincreases the threshold for long-term potentiation in rat dentate gyrus in vivo. Brain Res [J],736: 118-124.
GILBOA-GEFFEN A, LACOSTE P P, SOREQ L, et al. 2007. The thymic theme ofacetylcholinesterase splice variants in myasthenia gravis. Blood [J], 109: 4383-4391.
GILL K D, GUPTA V, SANDHIR R 2003. Ca2+/calmodulin-mediated neurotransmitter releaseand neurobehavioural deficits following lead exposure. Cell Biochem Funct [J], 21: 345-353.
GIORGETTI M, BACCIOTTINI L, GIOVANNINI M G, et al. 2000. Local GABAergicmodulation of acetylcholine release from the cortex of freely moving rats. Eur J Neurosci [J],12: 1941-1948.
GODWIN H A 2001. The biological chemistry of lead. Curr Opin Chem Biol [J], 5: 223-227.
GOEBEL S M, ALVESTAD R M, COULTRAP S J, et al. 2005. Tyrosine phosphorylation of theN-methyl-D-aspartate receptor is enhanced in synaptic membrane fractions of the adult rathippocampus. Brain Res Mol Brain Res [J], 142: 65-79.
GOLDBERG I E, ROSSI G C, LETCHWORTH S R, et al. 1998. Pharmacologicalcharacterization of endomorphin-1 and endomorphin-2 in mouse brain. J Pharmacol ExpTher [J], 286: 1007-1013.
GONG Y X, LV M, ZHU Y P, et al. 2007. Endogenous histamine inhibits the development ofmorphine-induced conditioned place preference. Acta Pharmacol Sin [J], 28: 10-18.
GORDON J N, TAYLOR A, BENNETT P N 2002. Lead poisoning: case studies. Br J ClinPharmacol [J], 53: 451-458.
GRAZIANO J, SLAVKOVICH V, LIU X, et al. 2004. A prospective study of prenatal andchildhood lead exposure and erythropoietin production. J Occup Environ Med [J], 46:924-929.
GRUART A, MUNOZ M D, DELGADO-GARCIA J M 2006. Involvement of the CA3-CA1synapse in the acquisition of associative learning in behaving mice. J Neurosci [J], 26:1077-1087.
GUAN Z Z, ZHANG X, RAVID R, et al. 2000. Decreased protein levels of nicotinic receptorsubunits in the hippocampus and temporal cortex of patients with Alzheimer's disease. JNeurochem [J], 74: 237-243.
GUILARTE T R, MCGLOTHAN J L 1998. Hippocampal NMDA receptor mRNA undergoessubunit specific changes during developmental lead exposure. Brain Res [J], 790: 98-107.
GUILARTE T R, MICELI R C 1992. Age-dependent effects of lead on [3H]MK-801 binding tothe NMDA receptor-gated ionophore: in vitro and in vivo studies. Neurosci Lett [J], 148:27-30.
GUILARTE T R, MICELI R C, JETT D A 1995. Biochemical evidence of an interaction of lead atthe zinc allosteric sites of the NMDA receptor complex: effects of neuronal development.Neurotoxicology [J], 16: 63-71.
GUO N, GARCIA M M, HARLAN R E 2008. A morphine-paired environment alters c-Fosexpression in the forebrain of rats displaying conditioned place preference or aversion. BehavNeurosci [J], 122: 1078-1086.
GURER H, OZGUNES H, NEAL R, et al. 1998. Antioxidant effects of N-acetylcysteine andsuccimer in red blood cells from lead-exposed rats. Toxicology [J], 128: 181-189.
HABERMANN E, CROWELL K, JANICKI P 1983. Lead and other metals can substitute forCa2+ in calmodulin. Arch Toxicol [J], 54: 61-70.
HANAFY S, SOLTAN M E 2004. Effects of Vitamin E pretreatment on subacute toxicity ofmixture of Co, Pb, and Hg nitrate-induced nephrotoxicity in rats. Environ Toxicol Pharmacol[J], 17: 159-167.
HANDELMANN G E, OLTON D S 1981. Spatial memory following damage to hippocampalCA3 pyramidal cells with kainic acid: impairment and recovery with preoperative training.Brain Res [J], 217: 41-58.
HANNAY T, LARKMAN A, STRATFORD K, et al. 1993. A common rule governs the synapticlocus of both short-term and long-term potentiation. Curr Biol [J], 3: 832-841.
HARTGRAVES S L, MENSAH P L, KELLY P H 1982. Regional decreases of cortical cholineacetyltransferase after lesions of the septal area and in the area of nucleus basalismagnocellularis. Neuroscience [J], 7: 2369-2376.
HARWELL T S, SPENCE M R, SANDS A, et al. 1996. Substance use in an inner-city familyplanning population. J Reprod Med [J], 41: 704-710.
HE S Q, ZHANG Z N, GUAN J S, et al. 2011. Facilitation of mu-opioid receptor activity bypreventing delta-opioid receptor-mediated codegradation. Neuron [J], 69: 120-131.
HEFTI F, DRAVID A, HARTIKKA J 1984. Chronic intraventricular injections of nerve growthfactor elevate hippocampal choline acetyltransferase activity in adult rats with partialsepto-hippocampal lesions. Brain Res [J], 293: 305-311.
HERROLD A A, SHEN F, GRAHAM M P, et al. 2009. Mirtazapine treatment after conditioningwith methamphetamine alters subsequent expression of place preference. Drug AlcoholDepend [J], 99: 231-239.
HESS D T, LIN L H, FREEMAN J A, et al. 1994. Modification of cysteine residues within G(o)and other neuronal proteins by exposure to nitric oxide. Neuropharmacology [J], 33:1283-1292.
HINOI E, BALCAR V J, KURAMOTO N, et al. 2002. Nuclear transcription factors in thehippocampus. Prog Neurobiol [J], 68: 145-165.
HUANG F, SCHNEIDER J S 2004. Effects of lead exposure on proliferation and differentiation ofneural stem cells derived from different regions of embryonic rat brain. Neurotoxicology [J],25: 1001-1012.
HUANG M, KREPKIY D, HU W, et al. 2004. Zn-, Cd-, and Pb-transcription factor IIIA:properties, DNA binding, and comparison with TFIIIA-finger 3 metal complexes. J InorgBiochem [J], 98: 775-785.
HUDA W, RILL L N, BENN D K, et al. 1997. Comparison of a photostimulable phosphor systemwith film for dental radiology. Oral Surg Oral Med Oral Pathol Oral Radiol Endod [J], 83:725-731.
HUSSAIN R J, PARSONS P J, CARPENTER D O 2000. Effects of lead on long-term potentiationin hippocampal CA3 vary with age. Brain Res Dev Brain Res [J], 121: 243-252.
IARUSHKIN V 1992. [Heavy metals in the mother-newborn infant biological system in thetechnology-related biogeochemical environment]. Gig Sanit [J]: 13-15.
IGA Y, ARISAWA H, ISE M, et al. 1996. Modulation of rhythmical slow activity, long-termpotentiation and memory by muscarinic receptor agonists. Eur J Pharmacol [J], 308: 13-19.
IKONOMIDOU C, BOSCH F, MIKSA M, et al. 1999. Blockade of NMDA receptors andapoptotic neurodegeneration in the developing brain. Science [J], 283: 70-74.
ISAAC J T, LUTHI A, PALMER M J, et al. 1998. An investigation of the expression mechanismof LTP of AMPA receptor-mediated synaptic transmission at hippocampal CA1 synapsesusing failures analysis and dendritic recordings. Neuropharmacology [J], 37: 1399-1410.
ITO M, SAKURAI M, TONGROACH P 1982. Climbing fibre induced depression of both mossyfibre responsiveness and glutamate sensitivity of cerebellar Purkinje cells. J Physiol [J], 324:113-134.
ITO Y, NIIYA Y, KURITA H, et al. 1985. Serum lipid peroxide level and blood superoxidedismutase activity in workers with occupational exposure to lead. Int Arch Occup EnvironHealth [J], 56: 119-127.
JANECKA A, FICHNA J, JANECKI T 2004. Opioid receptors and their ligands. Curr Top MedChem [J], 4: 1-17.
JANN M W 2000. Rivastigmine, a new-generation cholinesterase inhibitor for the treatment ofAlzheimer's disease. Pharmacotherapy [J], 20: 1-12.
JELLIFFE-PAWLOWSKI L L, MILES S Q, COURTNEY J G, et al. 2006. Effect of magnitudeand timing of maternal pregnancy blood lead (Pb) levels on birth outcomes. J Perinatol [J],26: 154-162.
JENTSCH J D, TAYLOR J R 1999. Impulsivity resulting from frontostriatal dysfunction in drugabuse: implications for the control of behavior by reward-related stimuli.Psychopharmacology (Berl) [J], 146: 373-390.
JI D, LAPE R, DANI J A 2001. Timing and location of nicotinic activity enhances or depresseshippocampal synaptic plasticity. Neuron [J], 31: 131-141.
JI X, LI C, LU Y, et al. 2007. Post-ischemic continuous administration of galantamine attenuatescognitive deficits and hippocampal neurons loss after transient global ischemia in gerbils.Neurosci Lett [J], 416: 92-95.
JIN-CHENG L, WEN Y, ZHAO Y, et al. 2008. Anti-arrhythmic effects of kappa-opioid receptorand its changes in ischemia and reperfusion. Arch Med Res [J], 39: 483-488.
JIN W, LEE N M, LOH H H, et al. 1992. Dual excitatory and inhibitory effects of opioids onintracellular calcium in neuroblastoma x glioma hybrid NG108-15 cells. Mol Pharmacol [J],42: 1083-1089.
JOHNSTON D, WILLIAMS S, JAFFE D, et al. 1992. NMDA-receptor-independent long-termpotentiation. Annu Rev Physiol [J], 54: 489-505.
JONES S, SUDWEEKS S, YAKEL J L 1999. Nicotinic receptors in the brain: correlatingphysiology with function. Trends Neurosci [J], 22: 555-561.
JOSSELYN S A, NGUYEN P V 2005. CREB, synapses and memory disorders: past progress andfuture challenges. Curr Drug Targets CNS Neurol Disord [J], 4: 481-497.
JUSKO T A, HENDERSON C R, LANPHEAR B P, et al. 2008. Blood lead concentrations < 10microg/dL and child intelligence at 6 years of age. Environ Health Perspect [J], 116: 243-248.
KACZOR A, MATOSIUK D 2002. Non-peptide opioid receptor ligands - recent advances. Part II- antagonists. Curr Med Chem [J], 9: 1591-1603.
KALIVAS P W 1993. Neurotransmitter regulation of dopamine neurons in the ventral tegmentalarea. Brain Res Brain Res Rev [J], 18: 75-113.
KASA P, RAKONCZAY Z, GULYA K 1997. The cholinergic system in Alzheimer's disease. ProgNeurobiol [J], 52: 511-535.
KATO N, YOSHIMURA H 1993. Tetanization during GABAA receptor activation induceslong-term depression in visual cortex slices. Neuropharmacology [J], 32: 511-513.
KERN M, WISNIEWSKI M, CABELL L, et al. 2000. Inorganic lead and calcium interactpositively in activation of calmodulin. Neurotoxicology [J], 21: 353-363.
KHACHATURIAN Z S 1984. Scientific challenges and opportunities related to Alzheimer'sdisease. Clin Pharm [J], 3: 522-523.
KIEDROWSKI L 2007. Critical role of sodium in cytosolic [Ca2+] elevations in culturedhippocampal CA1 neurons during anoxic depolarization. J Neurochem [J], 100: 915-923.
KIHARA T, SAWADA H, NAKAMIZO T, et al. 2004. Galantamine modulates nicotinic receptorand blocks Abeta-enhanced glutamate toxicity. Biochem Biophys Res Commun [J], 325:976-982.
KITCHEN I 1993. Lead toxicity and alterations in opioid systems. Neurotoxicology [J], 14:115-124.
KITCHEN I, MCDOWELL J, WINDER C, et al. 1984. Low-level lead exposure alters morphineantinociception in neonatal rats. Toxicol Lett [J], 22: 119-123.
KLECKNER N W, DINGLEDINE R 1988. Requirement for glycine in activation of
NMDA-receptors expressed in Xenopus oocytes. Science [J], 241: 835-837.
KLEIN M, SHAPIRO E, KANDEL E R 1980. Synaptic plasticity and the modulation of the Ca2+current. J Exp Biol [J], 89: 117-157.
KOIKE S 1997. [Low-level lead exposure and children's intelligence from recent epidemiologicalstudies in the U.S.A. and other countries to progress in reducing lead exposure and screeningin the U.S.A]. Nihon Eiseigaku Zasshi [J], 52: 552-561.
KOOB G F, MALDONADO R, STINUS L 1992. Neural substrates of opiate withdrawal. TrendsNeurosci [J], 15: 186-191.
KRIEGER D T 1983. Brain peptides: what, where, and why? Science [J], 222: 975-985.
KRNJEVIC K, REIFFENSTEIN R J, ROPERT N 1981. Disinhibitory action of acetylcholine inthe rat's hippocampus: extracellular observations. Neuroscience [J], 6: 2465-2474.
KRYGER G, SILMAN I, SUSSMAN J L 1999. Structure of acetylcholinesterase complexed withE2020 (Aricept): implications for the design of new anti-Alzheimer drugs. Structure [J], 7:297-307.
KUFAHL P R, ZAVALA A R, SINGH A, et al. 2009. c-Fos expression associated withreinstatement of cocaine-seeking behavior by response-contingent conditioned cues. Synapse[J], 63: 823-835.
KUMAR A, ZOU L, YUAN X, et al. 2002. N-methyl-D-aspartate receptors: transient loss ofNR1/NR2A/NR2B subunits after traumatic brain injury in a rodent model. J Neurosci Res [J],67: 781-786.
LACHOWICZ J E, DUFFY R A, RUPERTO V, et al. 2001. Facilitation of acetylcholine releaseand improvement in cognition by a selective M2 muscarinic antagonist, SCH 72788. Life Sci[J], 68: 2585-2592.
LAFOND J, HAMEL A, TAKSER L, et al. 2004. Low environmental contamination by lead inpregnant women: effect on calcium transfer in human placental syncytiotrophoblasts. JToxicol Environ Health A [J], 67: 1069-1079.
LANE-LADD S B, PINEDA J, BOUNDY V A, et al. 1997. CREB (cAMP responseelement-binding protein) in the locus coeruleus: biochemical, physiological, and behavioralevidence for a role in opiate dependence. J Neurosci [J], 17: 7890-7901.
LASLEY S M, GILBERT M E 1996. Presynaptic glutamatergic function in dentate gyrus in vivois diminished by chronic exposure to inorganic lead. Brain Res [J], 736: 125-134.
LASLEY S M, GILBERT M E 1999. Lead inhibits the rat N-methyl-d-aspartate receptor channelby binding to a site distinct from the zinc allosteric site. Toxicol Appl Pharmacol [J], 159:224-233.
LASLEY S M, GILBERT M E 2000. Glutamatergic components underlying lead-inducedimpairments in hippocampal synaptic plasticity. Neurotoxicology [J], 21: 1057-1068.
LAW P Y, WU J, KOEHLER J E, et al. 1981. Demonstration and characterization of opiateinhibition of the striatal adenylate cyclase. J Neurochem [J], 36: 1834-1846.
LEGROS J J, GILOT P, SERON X, et al. 1978. Influence of vasopressin on learning and memory.Lancet [J], 1: 41-42.
LEONARD A S, LIM I A, HEMSWORTH D E, et al. 1999. Calcium/calmodulin-dependentprotein kinase II is associated with the N-methyl-D-aspartate receptor. Proc Natl Acad Sci US A [J], 96: 3239-3244.
LEUNG L S, FU X W 1994. Factors affecting paired-pulse facilitation in hippocampal CA1neurons in vitro. Brain Res [J], 650: 75-84.
LI C, XING T, TANG M, et al. 2008a. Involvement of cyclin D1/CDK4 and pRb mediated byPI3K/AKT pathway activation in Pb2+ -induced neuronal death in cultured hippocampalneurons. Toxicol Appl Pharmacol [J], 229: 351-361.
LI S X, WANG Z R, LI J, et al. 2008b. Inhibition of Period1 gene attenuates themorphine-induced ERK-CREB activation in frontal cortex, hippocampus, and striatum inmice. Am J Drug Alcohol Abuse [J], 34: 673-682.
LI Y Q, LI F Q, WANG X Y, et al. 2008c. Central amygdala extracellular signal-regulated kinasesignaling pathway is critical to incubation of opiate craving. J Neurosci [J], 28: 13248-13257.
LINDAHL L S, BIRD L, LEGARE M E, et al. 1999. Differential ability of astroglia and neuronalcells to accumulate lead: dependence on cell type and on degree of differentiation. ToxicolSci [J], 50: 236-243.
LINDEN D J, CONNOR J A 1995. Long-term synaptic depression. Annu Rev Neurosci [J], 18:319-357.
LINDEN D J, SMEYNE M, CONNOR J A 1993. Induction of cerebellar long-term depression inculture requires postsynaptic action of sodium ions. Neuron [J], 11: 1093-1100.
LIU J, HAN D, LI Y, et al. 2010. Lead affects apoptosis and related gene XIAP and Smacexpression in the hippocampus of developing rats. Neurochem Res [J], 35: 473-479.
LOH H H, LIU H C, CAVALLI A, et al. 1998. mu Opioid receptor knockout in mice: effects onligand-induced analgesia and morphine lethality. Brain Res Mol Brain Res [J], 54: 321-326.
LOPEZ O L, HAMILTON R L, BECKER J T, et al. 2000. Severity of cognitive impairment andthe clinical diagnosis of AD with Lewy bodies. Neurology [J], 54: 1780-1787.
LORRIO S, SOBRADO M, ARIAS E, et al. 2007. Galantamine postischemia providesneuroprotection and memory recovery against transient global cerebral ischemia in gerbils. JPharmacol Exp Ther [J], 322: 591-599.
LOVEMAN E, GREEN C, KIRBY J, et al. 2006. The clinical and cost-effectiveness of donepezil,rivastigmine, galantamine and memantine for Alzheimer's disease. Health Technol Assess [J],10: iii-iv, ix-xi, 1-160.
LOVINGER D M, WONG K L, MURAKAMI K, et al. 1987. Protein kinase C inhibitorseliminate hippocampal long-term potentiation. Brain Res [J], 436: 177-183.
LU G, ZHOU Q X, KANG S, et al. 2010. Chronic morphine treatment impaired hippocampallong-term potentiation and spatial memory via accumulation of extracellular adenosine actingon adenosine A1 receptors. J Neurosci [J], 30: 5058-5070.
LUKAS R J, BENCHERIF M 1992. Heterogeneity and regulation of nicotinic acetylcholinereceptors. Int Rev Neurobiol [J], 34: 25-131.
LUO X, WEBER G A, ZHENG J, et al. 2003. C1q-calreticulin induced oxidative neurotoxicity:relevance for the neuropathogenesis of Alzheimer's disease. J Neuroimmunol [J], 135: 62-71.
MA H Y, LI H 2006. Kinds of heavy metal and placental barriers. Chin J Ind Hyg Occup Dis [J], 1:44.
MA Y Y, GUO C Y, YU P, et al. 2006. The role of NR2B containing NMDA receptor in placepreference conditioned with morphine and natural reinforcers in rats. Exp Neurol [J], 200:343-355.
MAELICKE A, ALBUQUERQUE E X 2000. Allosteric modulation of nicotinic acetylcholinereceptors as a treatment strategy for Alzheimer's disease. Eur J Pharmacol [J], 393: 165-170.
MAELICKE A, SAMOCHOCKI M, JOSTOCK R, et al. 2001. Allosteric sensitization of nicotinicreceptors by galantamine, a new treatment strategy for Alzheimer's disease. Biol Psychiatry[J], 49: 279-288.
MAGUIRE E A, BURGESS N, DONNETT J G, et al. 1998. Knowing where and getting there: ahuman navigation network. Science [J], 280: 921-924.
MALENKA R C, KAUER J A, PERKEL D J, et al. 1989. An essential role for postsynapticcalmodulin and protein kinase activity in long-term potentiation. Nature [J], 340: 554-557.
MALENKA R C, NICOLL R A 1999. Long-term potentiation--a decade of progress? Science [J],285: 1870-1874.
MALINOW R, MALENKA R C 2002. AMPA receptor trafficking and synaptic plasticity. AnnuRev Neurosci [J], 25: 103-126.
MANSOURI F A, MOTAMEDI F, FATHOLLAHI Y 1999. Chronic in vivo morphineadministration facilitates primed-bursts-induced long-term potentiation of Schaffercollateral-CA1 synapses in hippocampal slices in vitro. Brain Res [J], 815: 419-423.
MAO J, PRICE D D, MAYER D J 1995. Mechanisms of hyperalgesia and morphine tolerance: acurrent view of their possible interactions. Pain [J], 62: 259-274.
MARCO-CONTELLES J, DO CARMO CARREIRAS M, RODRIGUEZ C, et al. 2006. Synthesisand pharmacology of galantamine. Chem Rev [J], 106: 116-133.
MARECEK J, SHAPIRO I M, BURKE A, et al. 1983. Low-level lead exposure in childhoodinfluences neuropsychological performance. Arch Environ Health [J], 38: 355-359.
MARKOVAC J, GOLDSTEIN G W 1988. Picomolar concentrations of lead stimulate brainprotein kinase C. Nature [J], 334: 71-73.
MATSUO R, ASADA A, FUJITANI K, et al. 2001. LIRF, a gene induced during hippocampallong-term potentiation as an immediate-early gene, encodes a novel RING finger protein.Biochem Biophys Res Commun [J], 289: 479-484.
MATSUO R, MURAYAMA A, SAITOH Y, et al. 2000. Identification and cataloging of genesinduced by long-lasting long-term potentiation in awake rats. J Neurochem [J], 74:2239-2249.
MATTHES H W, MALDONADO R, SIMONIN F, et al. 1996. Loss of morphine-inducedanalgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptorgene. Nature [J], 383: 819-823.
MATTHES H W, SMADJA C, VALVERDE O, et al. 1998. Activity of the delta-opioid receptor ispartially reduced, whereas activity of the kappa-receptor is maintained in mice lacking themu-receptor. J Neurosci [J], 18: 7285-7295.
MATTHIES H, SCHROEDER H, BECKER A, et al. 2000. Lack of expression of long-termpotentiation in the dentate gyrus but not in the CA1 region of the hippocampus of mu-opioidreceptor-deficient mice. Neuropharmacology [J], 39: 952-960.
MAYER J H, STEFFENSEN S C, HENRIKSEN S J 1995. Site-selective acute desensitizationfollowing local administration of opioid in the hippocampus. Brain Res [J], 686: 134-142.
MCBRIDE W J, MURPHY J M, IKEMOTO S 1999. Localization of brain reinforcementmechanisms: intracranial self-administration and intracranial place-conditioning studies.Behav Brain Res [J], 101: 129-152.
MCDOWELL J, KITCHEN I 1988. Perinatal lead exposure alters the development of delta- butnot mu-opioid receptors in rat brain. Br J Pharmacol [J], 94: 933-937.
MELO J B, SOUSA C, GARCAO P, et al. 2009. Galantamine protects against oxidative stressinduced by amyloid-beta peptide in cortical neurons. Eur J Neurosci [J], 29: 455-464.
MENDOLA P, SELEVAN S G, GUTTER S, et al. 2002. Environmental factors associated with aspectrum of neurodevelopmental deficits. Ment Retard Dev Disabil Res Rev [J], 8: 188-197.
MIHAILOVA D, YAMBOLIEV I, ZHIVKOVA Z, et al. 1989. Pharmacokinetics of galanthaminehydrobromide after single subcutaneous and oral dosage in humans. Pharmacology [J], 39:50-58.
MIKE A, PEREIRA E F, ALBUQUERQUE E X 2000. Ca(2+)-sensitive inhibition by Pb(2+) ofalpha7-containing nicotinic acetylcholine receptors in hippocampal neurons. Brain Res [J],873: 112-123.
MILLAN M J 1990. Kappa-opioid receptors and analgesia. Trends Pharmacol Sci [J], 11: 70-76.
MILLER D K, NATION J R, JOST T E, et al. 2000. Differential effects of adult and perinatal leadexposure on morphine-induced locomotor activity in rats. Pharmacol Biochem Behav [J], 67:281-290.
MIYAKAWA T, YAMADA M, DUTTAROY A, et al. 2001. Hyperactivity and intacthippocampus-dependent learning in mice lacking the M1 muscarinic acetylcholine receptor. JNeurosci [J], 21: 5239-5250.
MIYAMOTO E 2006. Molecular mechanism of neuronal plasticity: induction and maintenance oflong-term potentiation in the hippocampus. J Pharmacol Sci [J], 100: 433-442.
MIYAMOTO M, KATO J, NARUMI S, et al. 1987. Characteristics of memory impairmentfollowing lesioning of the basal forebrain and medial septal nucleus in rats. Brain Res [J],419: 19-31.
MIYAMOTO M, NARUMI S, NAGAOKA A, et al. 1989. Effects of continuous infusion ofcholinergic drugs on memory impairment in rats with basal forebrain lesions. J PharmacolExp Ther [J], 248: 825-835.
MIYAMOTO M, SHINTANI M, NAGAOKA A, et al. 1985. Lesioning of the rat basal forebrainleads to memory impairments in passive and active avoidance tasks. Brain Res [J], 328:97-104.
MIZOGUCHI H, NARITA M, OJI D E, et al. 1999. The mu-opioid receptor gene-dose dependentreductions in G-protein activation in the pons/medulla and antinociception induced byendomorphins in mu-opioid receptor knockout mice. Neuroscience [J], 94: 203-207.
MONSMA F J, JR., MAHAN L C, MCVITTIE L D, et al. 1990. Molecular cloning andexpression of a D1 dopamine receptor linked to adenylyl cyclase activation. Proc Natl AcadSci U S A [J], 87: 6723-6727.
MONTENEGRO M F, BARBOSA F, JR., TANUS-SANTOS J E 2008. Assessment of howpregnancy modifies plasma lead and plasma/whole blood lead ratio in ALAD 1-1 genotypewomen. Basic Clin Pharmacol Toxicol [J], 102: 347-351.
MORIGUCHI S, MARSZALEC W, ZHAO X, et al. 2004. Mechanism of action of galantamineon N-methyl-D-aspartate receptors in rat cortical neurons. J Pharmacol Exp Ther [J], 310:933-942.
MORIGUCHI S, SHIODA N, HAN F, et al. 2009. Galantamine enhancement of long-termpotentiation is mediated by calcium/calmodulin-dependent protein kinase II and proteinkinase C activation. Hippocampus [J], 19: 844-854.
MORIYA H, TAKAGI Y, NAKANISHI T, et al. 1999. Affinity profiles of various muscarinicantagonists for cloned human muscarinic acetylcholine receptor (mAChR) subtypes andmAChRs in rat heart and submandibular gland. Life Sci [J], 64: 2351-2358.
MULDER A B, NORDQUIST R E, ORGUT O, et al. 2003. Learning-related changes in responsepatterns of prefrontal neurons during instrumental conditioning. Behav Brain Res [J], 146:77-88.
MURPHY K P, REID G P, TRENTHAM D R, et al. 1997. Activation of NMDA receptors isnecessary for the induction of associative long-term potentiation in area CA1 of the rathippocampal slice. J Physiol [J], 504 ( Pt 2): 379-385.
MURRAY E A 2007. The amygdala, reward and emotion. Trends Cogn Sci [J], 11: 489-497.
NARAHASHI T, MORIGUCHI S, ZHAO X, et al. 2004. Mechanisms of action of cognitiveenhancers on neuroreceptors. Biol Pharm Bull [J], 27: 1701-1706.
NARITA M, FUNADA M, SUZUKI T 2001. Regulations of opioid dependence by opioid receptortypes. Pharmacol Ther [J], 89: 1-15.
NARITA M, KANEKO C, MIYOSHI K, et al. 2006. Chronic pain induces anxiety withconcomitant changes in opioidergic function in the amygdala. Neuropsychopharmacology [J],31: 739-750.
NATION J R, LIVERMORE C L, BURKEY R T 1996. Chronic lead exposure attenuatessensitization to the locomotor-stimulating effects of cocaine. Drug Alcohol Depend [J], 41:143-149.
NEEDLEMAN H L, GATSONIS C A 1990. Low-level lead exposure and the IQ of children. Ameta-analysis of modern studies. JAMA [J], 263: 673-678.
NEHRU B, KANWAR S S 2007. Modulation by N-acetylcysteine of lead-induced alterations inrat brain: reduced glutathione levels and morphology. Toxicol Mech Methods [J], 17:289-293.
NESTLER E J 2001a. Molecular basis of long-term plasticity underlying addiction. Nat RevNeurosci [J], 2: 119-128.
NESTLER E J 2001b. Neurobiology. Total recall-the memory of addiction. Science [J], 292:2266-2267.
NESTLER E J, AGHAJANIAN G K 1997. Molecular and cellular basis of addiction. Science [J],278: 58-63.NEYLAN T C 2000. Memory and the Medial Temporal Lobe: Patient H. M. J NeuropsychiatryClin Neurosci [J], 12.
NIKFAR S, ABDOLLAHI M, SHARIFZADEH M, et al. 1998. Interaction between lead acetateand morphine on antinociception in mice by formalin test. Gen Pharmacol [J], 30: 489-493.
NISKAR A S, BUCHANAN S, MEYER P A 2005. A federal agency's role in fulfilling the publichealth core functions: the childhood lead poisoning prevention program model. J PublicHealth Manag Pract [J], 11: 50-58.
NOLTE J 1981. The human brainL an introduction to its functional anatomy. [M]. The C.V.Mosbycompany; St.Louis.
NORDBERG A 1999. PET studies and cholinergic therapy in Alzheimer's disease. Rev Neurol(Paris) [J], 155 Suppl 4: S53-63.
NORDBERG A, SVENSSON A L 1998. Cholinesterase inhibitors in the treatment of Alzheimer'sdisease: a comparison of tolerability and pharmacology. Drug Saf [J], 19: 465-480.
NOWAK L, BREGESTOVSKI P, ASCHER P, et al. 1984. Magnesium gates glutamate-activatedchannels in mouse central neurones. Nature [J], 307: 462-465.
OBERTO A, MARKS N, EVANS H L, et al. 1996. Lead (Pb+2) promotes apoptosis in newbornrat cerebellar neurons: pathological implications. J Pharmacol Exp Ther [J], 279: 435-442.
OLDS J 1972. Learning and the hippocampus. Rev Can Biol [J], 31: Suppl:215-238.
OLPE H R, KLEBS K, KUNG E, et al. 1987. Cholinomimetics induce theta rhythm and reducehippocampal pyramidal cell excitability. Eur J Pharmacol [J], 142: 275-283.
ONO T, NISHIJO H, UWANO T 1995. Amygdala role in conditioned associative learning. ProgNeurobiol [J], 46: 401-422.
PAGLIUSI S R, GERRARD P, ABDALLAH M, et al. 1994. Age-related changes in expression ofAMPA-selective glutamate receptor subunits: is calcium-permeability altered in hippocampalneurons? Neuroscience [J], 61: 429-433.
PALUCHA A, BRANSKI P, PILC A 2004. Selective mGlu5 receptor antagonist MTEP attenuatesnaloxone-induced morphine withdrawal symptoms. Pol J Pharmacol [J], 56: 863-866.
PAN Z Z 1998. mu-Opposing actions of the kappa-opioid receptor. Trends Pharmacol Sci [J], 19:94-98.
PAPEZ J W 1995. A proposed mechanism of emotion. 1937. J Neuropsychiatry Clin Neurosci [J],7: 103-112.
PARK S E, KIM N D, YOO Y H 2004. Acetylcholinesterase plays a pivotal role in apoptosomeformation. Cancer Res [J], 64: 2652-2655.
PARNETTI L, SENIN U, MECOCCI P 1997. Cognitive enhancement therapy for Alzheimer'sdisease. The way forward. Drugs [J], 53: 752-768.
PARTL S, HERBST H, SCHAEPER F, et al. 1998. GFAP gene expression is altered in young ratsfollowing developmental low level lead exposure. Neurotoxicology [J], 19: 547-551.
PASTERNAK G W 1995. Nitric oxide and opioid tolerance. NIDA Res Monogr [J], 147: 182-194.
PATERSON D, NORDBERG A 2000. Neuronal nicotinic receptors in the human brain. ProgNeurobiol [J], 61: 75-111.
PENG H, DERRICK B E, MARTINEZ J L, JR. 2003. Identification of upregulated SCG10mRNA expression associated with late-phase long-term potentiation in the rat hippocampalSchaffer-CA1 pathway in vivo. J Neurosci [J], 23: 6617-6626.
PENNARTZ C M, GROENEWEGEN H J, LOPES DA SILVA F H 1994. The nucleus accumbensas a complex of functionally distinct neuronal ensembles: an integration of behavioural,electrophysiological and anatomical data. Prog Neurobiol [J], 42: 719-761.
PERRY D C, XIAO Y, NGUYEN H N, et al. 2002. Measuring nicotinic receptors withcharacteristics of alpha4beta2, alpha3beta2 and alpha3beta4 subtypes in rat tissues byautoradiography. J Neurochem [J], 82: 468-481.
PERRY E K, TOMLINSON B E, BLESSED G, et al. 1978. Correlation of cholinergicabnormalities with senile plaques and mental test scores in senile dementia. Br Med J [J], 2:1457-1459.
PERSSON A I, THORLIN T, BULL C, et al. 2003. Mu- and delta-opioid receptor antagonistsdecrease proliferation and increase neurogenesis in cultures of rat adult hippocampalprogenitors. Eur J Neurosci [J], 17: 1159-1172.
PFRIEGER F W, GOTTMANN K, LUX H D 1994. Kinetics of GABAB receptor-mediatedinhibition of calcium currents and excitatory synaptic transmission in hippocampal neuronsin vitro. Neuron [J], 12: 97-107.
PHELPS D S, LITWACK G 1982. An electrophoretic characterization of the glucocorticoidresponse of the Fu5-5 rat hepatoma cell line. Eur J Biochem [J], 126: 407-415.
PICK M, PERRY C, LAPIDOT T, et al. 2006. Stress-induced cholinergic signaling promotesinflammation-associated thrombopoiesis. Blood [J], 107: 3397-3406.
PIERCE T L, WESSENDORF M W 2000. Immunocytochemical mapping ofendomorphin-2-immunoreactivity in rat brain. J Chem Neuroanat [J], 18: 181-207.
PIRKLE J L, BRODY D J, GUNTER E W, et al. 1994. The decline in blood lead levels in theUnited States. The National Health and Nutrition Examination Surveys (NHANES). JAMA[J], 272: 284-291.
PLATT B, CARPENTER D O, BUSSELBERG D, et al. 1995. Aluminum impairs hippocampallong-term potentiation in rats in vitro and in vivo. Exp Neurol [J], 134: 73-86.
PLUSQUELLEC P, MUCKLE G, DEWAILLY E, et al. 2007. The relation of low-level prenatallead exposure to behavioral indicators of attention in Inuit infants in Arctic Quebec.Neurotoxicol Teratol [J], 29: 527-537.
POCOCK S J, SMITH M, BAGHURST P 1994. Environmental lead and children's intelligence: asystematic review of the epidemiological evidence. BMJ [J], 309: 1189-1197.
POPIK P, LAYER R T, FOSSOM L H, et al. 1995. NMDA antagonist properties of the putativeantiaddictive drug, ibogaine. J Pharmacol Exp Ther [J], 275: 753-760.
POWER J M, SAH P 2002. Nuclear calcium signaling evoked by cholinergic stimulation inhippocampal CA1 pyramidal neurons. J Neurosci [J], 22: 3454-3462.
QUINN M R, HARRIS C L 1995. Lead inhibits Ca(2+)-stimulated nitric oxide synthase activityfrom rat cerebellum. Neurosci Lett [J], 196: 65-68.
RADCLIFFE K A, FISHER J L, GRAY R, et al. 1999. Nicotinic modulation of glutamate andGABA synaptic transmission of hippocampal neurons. Ann N Y Acad Sci [J], 868: 591-610.
RAMALHO R M, RIBEIRO P S, SOLA S, et al. 2004. Inhibition of the E2F-1/p53/Bax pathwayby tauroursodeoxycholic acid in amyloid beta-peptide-induced apoptosis of PC12 cells. JNeurochem [J], 90: 567-575.
RAMESH G T, JADHAV A L 2001. Levels of protein kinase C and nitric oxide synthase activityin rats exposed to sub chronic low level lead. Mol Cell Biochem [J], 223: 27-33.
RAMESH G T, MANNA S K, AGGARWAL B B, et al. 2001. Lead exposure activates nuclearfactor kappa B, activator protein-1, c-Jun N-terminal kinase and caspases in the rat brain.Toxicol Lett [J], 123: 195-207.
REDDY G R, DEVI B C, CHETTY C S 2007. Developmental lead neurotoxicity: alterations inbrain cholinergic system. Neurotoxicology [J], 28: 402-407.
RIEKKINEN P, JR., SIRVIO J, RIEKKINEN P 1990. The effects of THA on medial septallesion-induced memory defects. Pharmacol Biochem Behav [J], 36: 237-241.
ROBINSON T E, BERRIDGE K C 1993. The neural basis of drug craving: anincentive-sensitization theory of addiction. Brain Res Brain Res Rev [J], 18: 247-291.
ROBINSON T E, GORNY G, SAVAGE V R, et al. 2002. Widespread but regionally specificeffects of experimenter- versus self-administered morphine on dendritic spines in the nucleusaccumbens, hippocampus, and neocortex of adult rats. Synapse [J], 46: 271-279.
ROBINSON T E, KOLB B 2004. Structural plasticity associated with exposure to drugs of abuse.Neuropharmacology [J], 47 Suppl 1: 33-46.
RODRIGUES S M, SCHAFE G E, LEDOUX J E 2004. Molecular mechanisms underlyingemotional learning and memory in the lateral amygdala. Neuron [J], 44: 75-91.
ROGERS S L, FRIEDHOFF L T 1998. Pharmacokinetic and pharmacodynamic profile ofdonepezil HCl following single oral doses. Br J Clin Pharmacol [J], 46 Suppl 1: 1-6.
ROSEN J F 1992. Health effects of lead at low exposure levels. Expert consensus and rationale forlowering the definition of childhood lead poisoning. Am J Dis Child [J], 146: 1278-1281.
ROSLER M, ANAND R, CICIN-SAIN A, et al. 1999. Efficacy and safety of rivastigmine inpatients with Alzheimer's disease: international randomised controlled trial. BMJ [J], 318:633-638.
ROTHENBERG S J, KONDRASHOV V, MANALO M, et al. 2001. Seasonal variation in bonelead contribution to blood lead during pregnancy. Environ Res [J], 85: 191-194.
ROUTTENBERG A 1986. Synaptic plasticity and protein kinase C. Prog Brain Res [J], 69:211-234.
RUAN D Y, CHEN J T, ZHAO C, et al. 1998. Impairment of long-term potentiation andpaired-pulse facilitation in rat hippocampal dentate gyrus following developmental leadexposure in vivo. Brain Res [J], 806: 196-201.
SAIMI Y, KUNG C 2002. Calmodulin as an ion channel subunit. Annu Rev Physiol [J], 64:289-311.
SAKAGAMI M, TSUTSUI K 1999. The hierarchical organization of decision making in theprimate prefrontal cortex. Neurosci Res [J], 34: 79-89.
SANIN L H, GONZALEZ-COSSIO T, ROMIEU I, et al. 2001. Effect of maternal lead burden oninfant weight and weight gain at one month of age among breastfed infants. Pediatrics [J],107: 1016-1023.
SANTE A B, NOBRE M J, BRANDAO M L 2000. Place aversion induced by blockade of mu oractivation of kappa opioid receptors in the dorsal periaqueductal gray matter. BehavPharmacol [J], 11: 583-589.
SANTOS M D, ALKONDON M, PEREIRA E F, et al. 2002. The nicotinic allosteric potentiatingligand galantamine facilitates synaptic transmission in the mammalian central nervous system.Mol Pharmacol [J], 61: 1222-1234.
SASTRY B V, SADAVONGVIVAD C 1978. Cholinergic systems in non-nervous tissues.Pharmacol Rev [J], 30: 65-132.
SCHILSTROM B, IVANOV V B, WIKER C, et al. 2007. Galantamine enhances dopaminergicneurotransmission in vivo via allosteric potentiation of nicotinic acetylcholine receptors.Neuropsychopharmacology [J], 32: 43-53.
SCHOEPP D D 1993. The biochemical pharmacology of metabotropic glutamate receptors.Biochem Soc Trans [J], 21: 97-102.
SCHRATTENHOLZ A, PEREIRA E F, ROTH U, et al. 1996. Agonist responses of neuronalnicotinic acetylcholine receptors are potentiated by a novel class of allosterically actingligands. Mol Pharmacol [J], 49: 1-6.
SCHULER V, LUSCHER C, BLANCHET C, et al. 2001. Epilepsy, hyperalgesia, impairedmemory, and loss of pre- and postsynaptic GABA(B) responses in mice lacking GABA(B(1)).Neuron [J], 31: 47-58.
SCOTT L J, GOA K L 2000. Galantamine: a review of its use in Alzheimer's disease. Drugs [J],60: 1095-1122.
SCOVILLE W B, MILNER B 1957. Loss of recent memory after bilateral hippocampal lesions. JNeurol Neurosurg Psychiatry [J], 20: 11-21.
SEGAL M, AUERBACH J M 1997. Muscarinic receptors involved in hippocampal plasticity. LifeSci [J], 60: 1085-1091.
SEGUELA P, WADICHE J, DINELEY-MILLER K, et al. 1993. Molecular cloning, functionalproperties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeableto calcium. J Neurosci [J], 13: 596-604.
SHARP B M, ROY S, BIDLACK J M 1998. Evidence for opioid receptors on cells involved inhost defense and the immune system. J Neuroimmunol [J], 83: 45-56.
SHIMIZU E, TANG Y P, RAMPON C, et al. 2000. NMDA receptor-dependent synapticreinforcement as a crucial process for memory consolidation. Science [J], 290: 1170-1174.
SILBERGELD E K, FALES J T, GOLDBERG A M 1974. The effects of inorganic lead on theneuromuscular junction. Neuropharmacology [J], 13: 795-801.
SILVESTRELLI G, LANARI A, PARNETTI L, et al. 2006. Treatment of Alzheimer's disease:from pharmacology to a better understanding of disease pathophysiology. Mech Ageing Dev[J], 127: 148-157.
SIMMONS M L, CHAVKIN C 1996. Endogenous opioid regulation of hippocampal function. IntRev Neurobiol [J], 39: 145-196.
SIMONS T J 1993. Lead-calcium interactions in cellular lead toxicity. Neurotoxicology [J], 14:77-85.
SKOCZYNSKA A, GRUBER K, BELOWSKA-BIEN K, et al. 2007. [Risk of cadrdiovasculardiseases in lead-exposed workers of crystal glassworks. Part I. Effect of lead on bloodpressure and lipid metabolism]. Med Pr [J], 58: 475-483.
SMART T G 1997. Regulation of excitatory and inhibitory neurotransmitter-gated ion channels byprotein phosphorylation. Curr Opin Neurobiol [J], 7: 358-367.
SOFRONIEW M V, PEARSON R C 1985. Degeneration of cholinergic neurons in the basalnucleus following kainic or N-methyl-D-aspartic acid application to the cerebral cortex in therat. Brain Res [J], 339: 186-190.
SORA I, TAKAHASHI N, FUNADA M, et al. 1997. Opiate receptor knockout mice define mureceptor roles in endogenous nociceptive responses and morphine-induced analgesia. ProcNatl Acad Sci U S A [J], 94: 1544-1549.
SPAGNOLI A, LUCCA U, MENASCE G, et al. 1991. Long-term acetyl-L-carnitine treatment inAlzheimer's disease. Neurology [J], 41: 1726-1732.
SPANAGEL R, ALMEIDA O F, BARTL C, et al. 1994. Endogenous kappa-opioid systems inopiate withdrawal: role in aversion and accompanying changes in mesolimbic dopaminerelease. Psychopharmacology (Berl) [J], 115: 121-127.
STANTON P K, SEJNOWSKI T J 1989. Associative long-term depression in the hippocampusinduced by hebbian covariance. Nature [J], 339: 215-218.
STEELE P M, MAUK M D 1999. Inhibitory control of LTP and LTD: stability of synapse strength.J Neurophysiol [J], 81: 1559-1566.
STEINER D, AVIDOR-REISS T, SCHALLMACH E, et al. 2005. Regulation of adenylate cyclasetype VIII splice variants by acute and chronic Gi/o-coupled receptor activation. Biochem J [J],386: 341-348.
STEPHENSON J, CZEPULKOWSKI B, HIRST W, et al. 1996. Deletion of theacetylcholinesterase locus at 7q22 associated with myelodysplastic syndromes (MDS) andacute myeloid leukaemia (AML). Leuk Res [J], 20: 235-241.
STRINGER J L, GREENFIELD L J, HACKETT J T, et al. 1983. Blockade of long-termpotentiation by phencyclidine and sigma opiates in the hippocampus in vivo and in vitro.Brain Res [J], 280: 127-138.
STRUZYNSKA L, RAFALOWSKA U 1994. The effect of lead on dopamine, GABA andhistidine spontaneous and KCl-dependent releases from rat brain synaptosomes. ActaNeurobiol Exp (Wars) [J], 54: 201-207.
SUAREZ-ROCA H, MAIXNER W 1995. Morphine produces a biphasic modulation of substanceP release from cultured dorsal root ganglion neurons. Neurosci Lett [J], 194: 41-44.
SUI L, RUAN D Y 2000. Impairment of the Ca2+-permeable AMPA/kainate receptors by leadexposure in organotypic rat hippocampal slice cultures. Pharmacol Toxicol [J], 87: 204-210.
SUN X, TIAN X, TOMSIG J L, et al. 1999. Analysis of differential effects of Pb2+ on proteinkinase C isozymes. Toxicol Appl Pharmacol [J], 156: 40-45.
SUSZKIW J B 2004. Presynaptic disruption of transmitter release by lead. Neurotoxicology [J],25: 599-604.
SWEENEY J E, HOHMANN C F, MORAN T H, et al. 1988. A long-acting cholinesteraseinhibitor reverses spatial memory deficits in mice. Pharmacol Biochem Behav [J], 31:141-147.
TAKADA-TAKATORI Y, KUME T, SUGIMOTO M, et al. 2006. Neuroprotective effects ofgalanthamine and tacrine against glutamate neurotoxicity. Eur J Pharmacol [J], 549: 19-26.
TAKUMI Y, RAMIREZ-LEON V, LAAKE P, et al. 1999. Different modes of expression of AMPAand NMDA receptors in hippocampal synapses. Nat Neurosci [J], 2: 618-624.
TANIUCHI M, SCHWEITZER J B, JOHNSON E M, JR. 1986. Nerve growth factor receptormolecules in rat brain. Proc Natl Acad Sci U S A [J], 83: 1950-1954.
TAO R, AUERBACH S B 1995. Involvement of the dorsal raphe but not median raphe nucleus inmorphine-induced increases in serotonin release in the rat forebrain. Neuroscience [J], 68:553-561.
TEYLER T J, DISCENNA P 1984. Long-term potentiation as a candidate mnemonic device. BrainRes [J], 319: 15-28.
THOMPSON A M, GOSNELL B A, WAGNER J J 2002. Enhancement of long-term potentiationin the rat hippocampus following cocaine exposure. Neuropharmacology [J], 42: 1039-1042.
TOHGI H, ABE T, HASHIGUCHI K, et al. 1994. Remarkable reduction in acetylcholineconcentration in the cerebrospinal fluid from patients with Alzheimer type dementia.Neurosci Lett [J], 177: 139-142.
TORRES G, HOROWITZ J M 1999. Drugs of abuse and brain gene expression. Psychosom Med[J], 61: 630-650.
TOSCANO C D, HASHEMZADEH-GARGARI H, MCGLOTHAN J L, et al. 2002.Developmental Pb2+ exposure alters NMDAR subtypes and reduces CREB phosphorylationin the rat brain. Brain Res Dev Brain Res [J], 139: 217-226.
TOSCANO C D, MCGLOTHAN J L, GUILARTE T R 2003. Lead exposure alters cyclic-AMPresponse element binding protein phosphorylation and binding activity in the developing ratbrain. Brain Res Dev Brain Res [J], 145: 219-228.
TOSCANO C D, O'CALLAGHAN J P, GUILARTE T R 2005. Calcium/calmodulin-dependentprotein kinase II activity and expression are altered in the hippocampus of Pb2+-exposed rats.Brain Res [J], 1044: 51-58.
TROMMER B L, LIU Y B, PASTERNAK J F 1996. Long-term depression at the medial perforantpath-granule cell synapse in developing rat dentate gyrus. Brain Res Dev Brain Res [J], 96:97-108.
TSAO D A, YU H S, CHENG J T, et al. 2000. Alterations in beta-adrenergic receptor density andadenylate cyclase activity in the rat brain treated chronically with lead. Toxicology [J], 146:93-99.
TSIEN J Z, CHEN D F, GERBER D, et al. 1996. Subregion- and cell type-restricted geneknockout in mouse brain. Cell [J], 87: 1317-1326.
TZSCHENTKE T M, SCHMIDT W J 1998. Blockade of morphine- and amphetamine-inducedconditioned place preference in the rat by riluzole. Neurosci Lett [J], 242: 114-116.
UJIHARA H, ALBUQUERQUE E X 1992. Developmental change of the inhibition by lead ofNMDA-activated currents in cultured hippocampal neurons. J Pharmacol Exp Ther [J], 263:868-875.
UNGLESS M A, WHISTLER J L, MALENKA R C, et al. 2001. Single cocaine exposure in vivoinduces long-term potentiation in dopamine neurons. Nature [J], 411: 583-587.
VALLES R, CARDON A L, HEARD H M, et al. 2003. Morphine conditioned place preference isattenuated by perinatal lead exposure. Pharmacol Biochem Behav [J], 75: 295-300.
VAN DER KAM E L, DE VRY J, TZSCHENTKE T M 2009. The mGlu5 receptor antagonist2-methyl-6-(phenylethynyl)pyridine (MPEP) supports intravenous self-administration andinduces conditioned place preference in the rat. Eur J Pharmacol [J], 607: 114-120.
VANCE M A 2007. Hippocrates and lead poisoning. Am J Health Syst Pharm [J], 64: 1584.
VERINA T, ROHDE C A, GUILARTE T R 2007. Environmental lead exposure during early lifealters granule cell neurogenesis and morphology in the hippocampus of young adult rats.Neuroscience [J], 145: 1037-1047.
VETTER S W, LECLERC E 2003. Novel aspects of calmodulin target recognition and activation.Eur J Biochem [J], 270: 404-414.
VICKERS C, PATERSON A T 1986. Two types of chronic lead treatment in C57BL/6 mice:interaction with behavioural determinants of pain. Life Sci [J], 39: 47-53.
VICTOR M, ADAMS R D, COLLINS G H 1989. The Wernicke-Korsakoff Syndrome and RelatedNeurologic Disorders Due to Alcoholism and Malnutrition [M]. F.A.Davis Company;Philadelphia.
WADA E, WADA K, BOULTER J, et al. 1989. Distribution of alpha 2, alpha 3, alpha 4, and beta2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridizationhistochemical study in the rat. J Comp Neurol [J], 284: 314-335.
WAGNER J J, ALGER B E 1995. GABAergic and developmental influences on homosynapticLTD and depotentiation in rat hippocampus. J Neurosci [J], 15: 1577-1586.
WAGNER J J, CAUDLE R M, CHAVKIN C 1992. Kappa-opioids decrease excitatorytransmission in the dentate gyrus of the guinea pig hippocampus. J Neurosci [J], 12: 132-141.
WANG D, NODA Y, ZHOU Y, et al. 2007a. Synergistic effect of combined treatment withrisperidone and galantamine on phencyclidine-induced impairment of latent visuospatiallearning and memory: Role of nAChR activation-dependent increase of dopamine D1receptor-mediated neurotransmission. Neuropharmacology [J], 53: 379-389.
WANG D, NODA Y, ZHOU Y, et al. 2007b. Synergistic effect of galantamine with risperidone onimpairment of social interaction in phencyclidine-treated mice as a schizophrenic animalmodel. Neuropharmacology [J], 52: 1179-1187.
WANG X C, BURBACH J P, TENHAAF J, et al. 1986. Characterization and quantitation ofvasopressin metabolites in the rat brain by specific radioimmunoassay and high-pressureliquid chromatography. Sci Sin B [J], 29: 832-843.
WATT A J, VAN ROSSUM M C, MACLEOD K M, et al. 2000. Activity coregulates quantalAMPA and NMDA currents at neocortical synapses. Neuron [J], 26: 659-670.
WEVERS A, JESKE A, LOBRON C, et al. 1994. Cellular distribution of nicotinic acetylcholinereceptor subunit mRNAs in the human cerebral cortex as revealed by non-isotopic in situhybridization. Brain Res Mol Brain Res [J], 25: 122-128.
WICKENS J R, ABRAHAM W C 1991. The involvement of L-type calcium channels inheterosynaptic long-term depression in the hippocampus. Neurosci Lett [J], 130: 128-132.
WILKINS A, MAJED H, LAYFIELD R, et al. 2003. Oligodendrocytes promote neuronal survivaland axonal length by distinct intracellular mechanisms: a novel role foroligodendrocyte-derived glial cell line-derived neurotrophic factor. J Neurosci [J], 23:4967-4974.
WILLIAMS J T, CHRISTIE M J, MANZONI O 2001. Cellular and synaptic adaptationsmediating opioid dependence. Physiol Rev [J], 81: 299-343.
WONG T M, WU S 2003. Roles of kappa opioid receptors in cardioprotection against ischemia:the signaling mechanisms. Sheng Li Xue Bao [J], 55: 115-120.
XIE C W, LEWIS D V 1991. Opioid-mediated facilitation of long-term potentiation at the lateralperforant path-dentate granule cell synapse. J Pharmacol Exp Ther [J], 256: 289-296.
XU A J, CHEN Z, YANAI K, et al. 2002. Effect of3-[1-(phenylmethyl)-4-piperidinyl]-1-(2,3,4,5-tetrahydro-1H-1-benzazepin-8-yl)-1-propanone fumarate, a novel acetylcholinesterase inhibitor, on spatial cognitiveimpairment induced by chronic cerebral hypoperfusion in rats. Neurosci Lett [J], 331: 33-36.
XU J, LIAN L J, WU C, et al. 2008. Lead induces oxidative stress, DNA damage and alteration ofp53, Bax and Bcl-2 expressions in mice. Food Chem Toxicol [J], 46: 1488-1494.
XU J, YAN C H, YANG B, et al. 2009. The role of metabotropic glutamate receptor 5 indevelopmental lead neurotoxicity. Toxicol Lett [J], 191: 223-230.
XU J Y, HILL K P, BIDLACK J M 1998. The nitric oxide/cyclic GMP system at the supraspinalsite is involved in the development of acute morphine antinociceptive tolerance. J PharmacolExp Ther [J], 284: 196-201.
XU S Z, SHAN C J, BULLOCK L, et al. 2006. Pb2+ reduces PKCs and NF-kappaB in vitro. CellBiol Toxicol [J], 22: 189-198.
YAN D, WANG L, MA F L, et al. 2008. Developmental exposure to lead causes inherent changeson voltage-gated sodium channels in rat hippocampal CA1 neurons. Neuroscience [J], 153:436-445.
YANG X, CRISWELL H E, SIMSON P, et al. 1996. Evidence for a selective effect of ethanol onN-methyl-d-aspartate responses: ethanol affects a subtype of the ifenprodil-sensitiveN-methyl-d-aspartate receptors. J Pharmacol Exp Ther [J], 278: 114-124.
YAO W D, GAINETDINOV R R, ARBUCKLE M I, et al. 2004. Identification of PSD-95 as aregulator of dopamine-mediated synaptic and behavioral plasticity. Neuron [J], 41: 625-638.
YIN W, ZHANG P, HUANG J H, et al. 2009. Stimulation of kappa-opioid receptor reducesisoprenaline-induced cardiac hypertrophy and fibrosis. Eur J Pharmacol [J], 607: 135-142.
YU Z, CHENG G, HU B 1997. Mechanism of colchicine impairment on learning and memory,and protective effect of CGP36742 in mice. Brain Res [J], 750: 53-58.
ZAGON I S, MCLAUGHLIN P J 1977a. Effect of chronic maternal methadone exposure onperinatal development. Biol Neonate [J], 31: 271-282.
ZAGON I S, MCLAUGHLIN P J 1977b. Morphine and brain growth retardation in the rat.Pharmacology [J], 15: 276-282.
ZALUTSKY R A, NICOLL R A 1990. Comparison of two forms of long-term potentiation insingle hippocampal neurons. Science [J], 248: 1619-1624.
ZAREI M M, RADCLIFFE K A, CHEN D, et al. 1999. Distributions of nicotinic acetylcholinereceptor alpha7 and beta2 subunits on cultured hippocampal neurons. Neuroscience [J], 88:755-764.
ZARRINDAST M R, BABAPOOR-FARROKHRAN S, REZAYOF A 2008. Involvement ofopioidergic system of the ventral hippocampus, the nucleus accumbens or the centralamygdala in anxiety-related behavior. Life Sci [J], 82: 1175-1181.
ZHANG D X, LEVY W B 1993. Bicuculline permits the induction of long-term depression byheterosynaptic, translaminar conditioning in the hippocampal dentate gyrus. Brain Res [J],613: 309-312.
ZHANG H S, ZHAO X L, SONG L H, et al. 1998. Inhibition of the specific 3H-DL-Glu bindingin the hippocampus of rat brain by lead. Biomed Environ Sci [J], 11: 81-86.
ZHANG H X, ZHANG W, JIN H W, et al. 2004. Galantamine blocks cloned Kv2.1, but not Kv1.5potassium channels. Brain Res Mol Brain Res [J], 131: 136-140.
ZHANG X J, YANG L, ZHAO Q, et al. 2002a. Induction of acetylcholinesterase expressionduring apoptosis in various cell types. Cell Death Differ [J], 9: 790-800.
ZHANG X Y, LIU A P, RUAN D Y, et al. 2002b. Effect of developmental lead exposure on theexpression of specific NMDA receptor subunit mRNAs in the hippocampus of neonatal ratsby digoxigenin-labeled in situ hybridization histochemistry. Neurotoxicol Teratol [J], 24:149-160.
ZHANG Y L, ZHANG P B, QIU S D, et al. 2006. Effects of ketamine-midazolam anesthesia onthe expression of NMDA and AMPA receptor subunit in the peri-infarction of rat brain. ChinMed J (Engl) [J], 119: 1555-1562.
ZHAO W F, RUAN D Y, XU Y Z, et al. 1999. The effects of chronic lead exposure on long-termdepression in area CA1 and dentate gyrus of rat hippocampus in vitro. Brain Res [J], 818:153-159.
ZHONG W, DONG Z, TIAN M, et al. 2006. Opiate withdrawal induces dynamic expressions ofAMPA receptors and its regulatory molecule CaMKIIalpha in hippocampal synapses. LifeSci [J], 79: 861-869.
ZHOU L F, ZHU Y P 2006. Changes of CREB in rat hippocampus, prefrontal cortex and nucleusaccumbens during three phases of morphine induced conditioned place preference in rats. JZhejiang Univ Sci B [J], 7: 107-113.